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ABSTRACT
Designing and engineering molecules not only tests our understanding of nature but also
plays an important role in improving both human health and industrial productivity. Two
such examples are drug discovery, which aims to design new molecules to treat diseases,
and protein engineering, which develops useful proteins for medical purposes or catalyz-
ing industrial chemical reactions. Drug discovery and protein engineering are both time-
consuming and financially expensive processes because they require multiple rounds of
trial-and-error. One effective path to reducing these costs and accelerating these processes
is through the development of computational methods that rationalize the course of design
and engineering. Facilitated by methodological developments and the increasing availabil-
ity of computational resources, computational strategies are becoming effective approaches
to assist drug discovery and protein engineering tasks. In this dissertation, I describe the de-
velopment of novel computational methodologies for drug discovery and protein engineer-
ing that exploit evolving accelerated computing architectures and the intersection between
statistical approaches and statistical mechanics.
Protein-ligand docking and free energy calculations are widely employed computa-
tional methods in drug discovery. In the dissertation, I first describe the development of an
accelerated version of the protein-ligand docking method, CDOCKER, by introducing two
new features— fast Fourier transform based docking and parallel simulated annealing, both
of which utilize the parallel computing power of graphical processing units (GPUs). These
advances not only accelerate CDOCKER by more than an order of magnitude but also pro-
vide an approach to calculate an upper bound on the docking accuracy of current scoring
vii
functions. In the second project that is directed toward a more rigorous assessment of a
ligand’s binding affinity for a receptor, I introduced two new methods for protein-ligand
binding free energy calculations: the Gibbs sampler  -dynamics (GSLD) methodology
and Rao-Blackwell estimators (RBE) for improved analysis of the simulation results from
GSLD. Compared with the original  -dynamics approach, GSLD is more flexible, easier
to implement, and retains the capacity to calculate free energies for multiple ligands in a
single simulation. Compared with the empirical estimator used in  -dynamics, RBE has
the advantages of being an unbiased estimator that does not depend on ad hoc cutoff values
as previously used in the empirical estimators associated with  -dynamics. Additionally,
RBE has smaller variance than the empirical estimators.
In the realm of protein engineering, I investigated the development and application of
variational auto-encoder (VAE) models to infer protein stability, evolution, and fitness land-
scapes based on alignments of protein sequences. VAE models are probabilistic generative
models that embed discrete sequences in a lower dimensional continuous latent space. Uti-
lizing the multiple sequence alignment from a protein family as training data, VAE models
learn a probability distribution of sequences for the protein family. The probability dis-
tribution may then by employed to predict protein stability changes upon mutation. The
embedding of sequences in a low dimensional latent space not only provides an approach
to visualize a protein family’s sequence space, but also captures evolutionary relationships
between sequences. Together with experimental fitness data, the embedding enables the vi-
sualization and expression of the fitness landscape in a low dimensional continuous space.
Exploiting the rapidly increasing amount of protein sequence data resulting from advances
in sequencing technology, we demonstrate that these features of the VAE models are of
significance for studying protein properties and evolution as well as guiding protein engi-
neering efforts.
viii
CHAPTER 1
Introduction
Designing and engineering molecules that have specified properties for good use is one of
the goals of natural sciences. It not only tests our understanding of nature but also plays an
important role in improving both human health and industrial productivity[1]. Two such
examples are drug discovery [2] and protein engineering [3], which will be the focus of
this dissertation. Drug discovery aims to design molecules to treat or even cure diseases,
which is essential to continuously improve human health. Protein engineering designs new
proteins or modifies existing proteins to make useful proteins such as antibodies and protein
drugs for medical purposes, and enzymes for catalyzing industrial chemical reactions.
Drug discovery and protein engineering are both time-consuming and financially ex-
pensive processes. For instance, developing a new drug requires on average one billion
dollars and ten years of effort [2]. One of the reasons for the high cost is that these pro-
cesses require multiple rounds of trial-and-error[2]. Therefore, one path to reducing the
cost is to develop methods that can rationalize the course of designing and engineering
processes. A particularly effective approach is developing computational methods that can
make predictions and help guide the design and engineering processes [4, 5]. As an ex-
ample, the computational methods — protein-ligand docking and free energy calculations
— have been widely employed in assisting drug discovery processes [4, 6]. Specifically,
the protein-ligand docking method is used to search a large library of small molecules to
identify molecules that can potentially bind with a target protein [4]. The free energy cal-
culation approach is for more rigorous evaluation of a ligand’s binding affinity with target
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proteins [6]. In the realm of protein engineering, computational methods for designing
proteins and predicting protein property change upon mutation are also increasingly used
for guiding protein engineering efforts [5]. With continuous computational methodolog-
ical developments and the increasing availability of computing resources, computational
approaches are becoming more and more effective in assisting both drug discovery and
protein engineering [4, 5].
In this dissertation, I describe the development and implementation of novel computa-
tional methodologies for drug discovery and protein engineering that exploit both evolving
accelerated computing architectures and the intersection between statistics and statistical
mechanics. In chapter 2, I describe the development and implementation of two new fea-
tures — fast Fourier (FFT) transform docking and parallel simulated annealing — added
to the protein-ligand docking method, CHARMM DOCKER(CDOCKER) [7]. These ad-
vances not only accelerate CDOCKER by more than an order of magnitude but also provide
an approach to calculate an upper bound on the docking accuracy that can be achieved with
current functions used in scoring docked poses. In chapter 3, two new methods for cal-
culating protein-ligand binding free energies — Gibbs sampler  -dynamics (GSLD) and
Rao-Blackwell estimators (RBE) — are described [8]. GSLD is a new sampling method
that combines the Gibbs sampler in statistics and the  -dynamics approach in computa-
tional chemistry. RBE is introduced to replace the empirical estimator used in the original
 -dynamics to better analyze the simulation results from GSLD. In chapter 4, I describe
the development and application of variational auto-encoders (VAE) models to infer infor-
mation regarding protein stability, evolution, and fitness landscapes using alignments of
multiple protein sequences. These features of the VAE models are of significance for both
studying protein properties and evolution and guiding protein engineering efforts.
The organization within chapter 2, 3, and 4 follows the same structure. At the begin-
ning of each chapter, an introduction is given to provide an overview of the specific field,
followed by a review of existing corresponding computational methods. After the review,
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novel computational methods developed in the dissertation are described in detail. These
novel methods are applied and compared with existing methods on different systems. Then
each chapter is ended by conclusions or discussions on the novel computational methods.
3
CHAPTER 2
Protein-Ligand Docking
Ding, Xinqiang, Ryan L. Hayes, Jonah Z. Vilseck, Murchtricia K. Charles, and Charles L.
Brooks III. “CDOCKER and  -dynamics for prospective prediction in D3R Grand Chal-
lenge 2.” Journal of computer-aided molecular design 32, no. 1 (2018): 89-102.
Ding, Xinqiang, Yanming Wang, Charles L. Brooks III “Accelerated CDOCKER with fast
Fourier transform docking and parallel simulated annealing on graphical processing units.”
in preparation.
2.1 Introduction
Protein-ligand docking methods aim to predict how ligands bind with a target protein, i.e.,
binding poses of ligands and their binding affinities [9]. They are widely employed in
drug discovery processes to virtually screen libraries of a large number of small molecules
to search for hit compounds that might be able to strongly bind with target proteins [4].
Today multiple off-the-shelf protein-ligand docking programs, either commercial or free,
are available for use [10], such as CDOCKER[7], Autodock[11], Autodock Vina[12],
DOCK[13], and Glide[14, 15]. Most of protein-ligand docking programs consist of two
essential components — a scoring function and a search algorithm [7]. The scoring func-
tion quantifies the fit between a ligand’s binding pose and the target protein and is expected
to be able to differentiate the correct binding pose from incorrect ones by the assumption
that the correct binding pose has the best score. When used to predict binding affinities, the
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scoring function is also expected to approximate the binding free energy between ligands
and target proteins. The search algorithm is utilized to sample potential ligand binding
poses and identify the binding pose with the best score. Because scoring functions used in
protein-ligand docking programs are not convex functions and might have multiple local
minimums, heuristic search algorithms such as genetic algorithms and simulated annealing
are often utilized in protein-ligand docking programs[7, 12].
CDOCKER[7], a CHARMM[16] module for protein-ligand docking, is one of the
protein-ligand docking programs that are widely used in both academia and industry for
drug discovery. It uses the interaction energies between proteins and ligands calculated
with the CHARMM force field for proteins and the CGenFF force field [17] for ligands as
its scoring function. To search for the lowest energy poses of ligands, CDOCKER utilizes
molecular dynamics (MD) based simulated annealing followed by energy minimization. In
the MD based simulated annealing, MD is used to simulate the dynamics of protein-ligand
interactions and the temperature of MD first increases to a high value and then slowly de-
creases. As the temperature of MD decreases, ligands are expected to adopt to low energy
poses. Resulting ligand poses from simulated annealing are further optimized by energy
minimization. As the MD-based simulated annealing is a heuristic search approach, it is
not guaranteed that the ligand will converge to the lowest energy pose in each trial of MD-
based simulated annealing. To increase the chance that the lowest energy pose of the ligand
is identified, multiple trials of simulated annealing are needed. In each trial, the ligand is
first initialized with a random conformation, a random orientation, and a random position
within the binding pocket before going through the MD-based simulated annealing and en-
ergy minimization. After the energy minimization, the resulting poses, one from each trial,
are ranked by their interaction energies with the protein and the pose with the lowest inter-
action energy is predicted to be the binding pose. In a typical application of CDOCKER,
a large number of ligands need to be docked with a protein. Therefore, the docking pro-
cedure has to run fast enough to make the method practical. To accelerate the docking
5
procedure and help search for the lowest energy poses of ligands, CDOCKER utilizes a
grid representation of the binding pocket and soft-core potentials[7, 9], respectively, which
will be described in detail in theMethods section. In this chapter, two new features — fast
Fourier transform (FFT) [18] docking and parallel MD simulated annealing — are added
to CDOCKER to help quantify the accuracy of CDOCKER scoring function and to further
accelerate the search algorithm in CDOCKER.
2.1.1 Fast Fourier transform docking.
The FFT approach for docking was first used in rigid protein-protein docking [19]. In this
approach, proteins are represented as 3 dimensional grids such that the surface complemen-
tarity of two proteins can be formulated as the correlation function between two grids [19].
Calculating the correlation function between two grids can be greatly accelerated using the
FFT algorithm[20]. Since its first use in protein-protein docking [19], the FFT approach has
been extended and improved in several aspects. In addition to the original potential term
representing protein shape complementarity [19], potential terms representing desolvation
and electrostatic interactions were added into the scoring function [21, 22, 23] to more ac-
curately model the physical interactions between proteins. Moreover, the FFT approach
was further accelerated by using spherical polar Fourier correlations to speedup the rota-
tional space search [24, 25, 26] and by utilizing the parallel computing power of graphics
processor units (GPUs) [27, 28]. With these extensions and improvements, the FFT ap-
proach has been widely adopted in multiple protein-protein docking programs [25, 23, 29].
In contrast to FFT’s wide application in protein-protein docking, its application in
protein-ligand docking is largely unexplored [30]. One difficulty in adopting the FFT ap-
proach for protein-ligand docking is to represent the scoring function as a correlation func-
tion between grids, as the scoring function used in protein-ligand docking is often more
complicated than that in protein-protein docking. In addition, the FFT approach assumes
both protein and ligand are rigid bodies, whereas, in protein-ligand docking, at least the
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ligand needs to be flexible. Therefore multiple FFTs are required to search the ligand’s
conformation space. This in turn requires a fast implementation of FFT. Otherwise running
multiple FFTs will take too much time to be practical.
In this chapter, we investigated the use of the FFT approach for protein-ligand docking
in the context of CDOCKER where the CHARMM force field [16, 17] was used as the
scoring function. The interaction energy, including electrostatic and van der Waals energy,
between proteins and ligands are represented as the sum of multiple correlation functions
between multiple pairs of grids and the calculation of correlation functions is accelerated
using FFTs. Moreover, calculating multiple FFTs is further accelerated using GPUs.
2.1.2 Parallel MD-based simulated annealing with GPUs.
One of the advances in using MD simulations to study both chemical and biological sys-
tems has been the utilization of GPUs in running MD [31, 32, 33, 34]. Compared with the
traditional central processing units (CPUs), the parallel computing power of GPUs enables
us to run MD simulations orders of magnitude faster and simulate longer timescale dynam-
ics of chemical and biological systems, which makes MD suitable to study processes that
are not accessible before [31, 32, 33, 34]. Although GPUs have been widely employed
in running MD simulations of large chemical and biological systems, they are rarely used
to accelerate protein-ligand docking methods. In this chapter, we investigated the utiliza-
tion of GPU computing to accelerate CDOCKER for protein-ligand docking by running
MD-based simulated annealing of multiple copies of ligands in parallel on GPUs.
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2.2 Methodology
2.2.1 Grids and soft-core potentials in CDOCKER
In CDOCKER’s docking protocol, most of the computational time is spent on calculating
forces on ligand atoms and the ligand’s interaction energy with the protein for a large
number of ligand poses. To accelerate the force and energy calculation a grid representation
of the binding pocket is used. Specifically, the binding pocket inside a protein is discretized
into a 3 dimensional grid. Probe atoms are placed on each of the grid points and their
interaction energies with the protein are saved in a lookup table. Then the force and the
interaction energy of a ligand atom with the protein can be rapidly calculated by looking
up values in the tables, instead of explicitly calculating its interaction with all of the protein
atoms.
Soft-core potentials in CDOCKER are used to smooth the energy landscape, which
can help the MD-based simulated annealing to escape from local minima and identify the
ligand pose with the lowest energy. Specifically, when using soft-core potentials, the van
der Waals, electrostatic attractive, and electrostatic repulsive energies are approximated
using the formula:
Eij = Emax   a · rbij if |E⇤ij| >
|Emax|
2
, (2.1)
where E⇤ij is regular interaction energy; Emax is a parameter controlling the “softness” of
the potential; a and b are determined using the condition that the energy and the force
calculated using the new formula 2.1 have to be equal to that with the regular formula at
the switch distance at which |E⇤ij| = |Emax|/2. Three sets of values for parameter Emax are
used in this study and they are summarized in Table 2.1
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Table 2.1: Soft-core potentials with different “softness”
name E⇤max(vdw) E⇤max(att) E⇤max(rep)
soft-core potential I 0.6 -0.4 8.0
soft-core potential II 3.0 -20.0 40.0
soft-core potential III 100 -100 100
* Emax(vdw), Emax(att) and Emax(rep) in the unit of
kcal/mol are parameters for the van der Waals, electro-
static attractive, and electrostatic repulsive interactions,
respectively.
2.2.2 Fast Fourier transform (FFT) docking
2.2.2.1 Representing non-bonded interaction energy between proteins and ligands
as correlation functions between grids.
In order to use the FFT approach for protein-ligand docking, the interaction energy between
proteins and ligands needs to be expressed as correlation functions between grids. Because
CDOCKER uses the CHARMM force field [16, 17] as its scoring function, the interaction
between proteins and ligands includes electrostatic and van der Waals interactions [7].
The electrostatic interaction energy between proteins and ligands is calculated as
Uelec =
X
i2L
X
j2P
1
4⇡✏
qiqj
|ri   rj| =
X
i2L
qi ·
X
j2P
1
4⇡✏
qj
|ri   rj| =
X
i2L
qi · Velec(ri), (2.2)
where L and P are collections of ligand atoms and protein atoms, respectively; qi and qj
are atom partial charges; ri and rj are atom coordinates. Velec(ri) =
P
j2P
1
4⇡✏
qj
|ri rj | is
the protein electrostatic potential at position ri. As equation (2.2) shows, the electrostatic
interaction energy between protein and ligand atoms can be calculated as inner-product be-
tween the ligand atoms’ charge vector qL = (qi)i2L and the protein electrostatic potential
vector Velec = (Velec(ri))i2L. However, the protein electrostatic potential vector Velec still
depends on positions of ligand atoms that are not known in advance. To get rid of this de-
pendency, grid representations are used for both the protein electrostatic potential and the
ligand atoms’ charges (Fig. 2.1). Specifically, the binding pocket of a protein is discretized
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(A)
(B)
(C) (D)
Figure 2.1: The electrostatic interaction energy between proteins and ligands can be calcu-
lated as a cross correlation function between the protein electrostatic potential grid and the
ligand charge grid. (A) The bind pocket in the protein is discretized into a 3 dimensional
grid with equal spacing distance. (B) Charges of ligand atoms are distributed onto a 3 di-
mensional grid which has the same spacing distance and the same number of grid points as
the potential grid in (A). (C,D) As the ligand translates within the binding pocket by mul-
tiple units of the spacing distance, the electrostatic interaction energy can be approximated
using a cross correlation between the protein potential grid and the ligand charge grid. (C)
and (D) corresponds to the cases Uelec(0, 0, 0) and Uelec(0, 1, 0), respectively.
using a 3 dimensional grid and protein electrostatic potentials at all the grid points are cal-
culated and saved in a lookup table (Fig. 2.1A). The protein electrostatic potential at the
grid point (l,m, n) is represented as V gridelec (l,m, n). Because the protein electrostatic poten-
tial is calculated only at the grid points, in order to calculate the electrostatic interaction
energy between proteins and ligands, the partial charges of ligand atoms are distributed
onto a 3 dimensional grid (Fig. 2.1B) in a trilinear manner (Fig. S1). The aggregated
charge at the grid point (l,m, n) is represented as Qgrid(l,m, n). Then the electrostatic in-
teraction energy between protein atoms and ligand atoms can be approximated using the
inner-product of protein electrostatic potential grid and ligand charge grid (Fig. 2.1C):
Uelec ⇡
Nx 1X
l=0
Ny 1X
m=0
Nz 1X
n=0
Qgrid(l,m, n) · V gridelec (l,m, n), (2.3)
whereNx, Ny, andNz are numbers of grid points alongX ,Y ,and Z direction, respectively.
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Moreover, when the ligand is translated with the binding pocket by i, j, and k grid spacing
units in the X, Y , and Z direction, respectively, the electrostatic potential energy between
the protein and ligand can be similarly approximated using (Fig. 2.1D):
Uelec(i, j, k) ⇡
Nx 1X
l=0
Ny 1X
m=0
Nz 1X
n=0
Qgrid(l,m, n) · V gridelec (l + i,m+ j, n+ k), (2.4)
where V gridelec is extended into a periodic grid, i.e., V
grid
elec (l,m, n) = V
grid
elec (l (modNx),m (modNy),
n (mod Nz)). As shown in Eq. 2.4, as the ligand moves within the binding pocket by dis-
tances of multiple units of grid spacing in each direction, the electrostatic interaction energy
between the protein and ligand can be approximated as a cross correlation function between
the protein electrostatic potential grid V gridelec and the ligand charge grid Qgrid. An advantage
of using the grid representation, as in Eq. 2.4, over that in Eq. 2.2 is V gridelec is independent of
the ligand and can be calculated with only the protein. Similarly, grid Qgrid is independent
of the protein and can be calculated with only the ligand.
The van der Waals interaction energy between proteins and ligands is calculated using
the Lennard-Jones potential:
Uvdw =
X
i2L
X
j2P
✏ij
" 
rminij
rij
!12
  2
 
rminij
rij
!6#
=
X
i2L
X
j2P
p
✏i✏j
" 
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min
j )/2
|ri   rj|
!12
  2
 
(rmini + r
min
j )/2
|ri   rj|
!6#
=
X
i2L
p
✏i · Vvdw(ri, rmini ), (2.5)
where rmini , rminj , ✏i, ✏j are parameters of the Lennard-Jones potential and are parts of the
CHARMM force field;
Vvdw(ri, r
min
i ) =
X
j2P
p
✏j
" 
(rmini + r
min
j )/2
|ri   rj|
!12
  2
 
(rmini + r
min
j )/2
|ri   rj|
!6#
. (2.6)
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The Eq. 2.5 for van der Waals energy is similar to that in Eq. 2.2, except that Vvdw(ri, rmini )
depends on not only ligand coordinates ri but also parameters rmini , whereas Velec(ri) only
depends on ligand coordinates ri. Because of this difference, the approach used to repre-
sent the electrostatic energy between proteins and ligands as a cross correlation function
between a pair of grids can not be applied to van der Waals interaction directly. In the
CHARMM force field, parameters rmin of ligand atoms depend on their atom types and the
total number of atom types is finite. Therefore, there are only a finite number of possible
values for rmin. Taking advantage of this fact, we can group the terms in Eq. 2.5 based on
the value of rmin:
Uvdw =
X
i2L
p
✏i · Vvdw(ri, rmini ) =
X
rmin2Rmin
X
i2Lrmin
p
✏i · V rminvdw (ri) =
X
rmin2Rmin
U r
min
vdw , (2.7)
whereRmin is the set of possible values of rmin for ligand atoms and Lrmin is the set of ligand
atoms that have the parameter of rmin. The individual van der Waals energy corresponding
rmin is U rminvdw =
P
i2Lrmin
p
✏i ·V rminvdw (ri), which is similar to the Eq. 2.2 and can be calculated
as a cross correlation function between grids using the same approach used for calculating
the electrostatic energy. Therefore, the total van der Waals interaction energy between pro-
teins and ligands can be approximated as the sum of multiple correlation functions between
multiple pairs of grids.
2.2.2.2 Calculating cross correlation functions between grids using FFTs in parallel
on GPUs.
Based on the convolution theorem [20], the cross correlation function for electrostatic en-
ergy in Eq. 2.4 can be calculated by applying a Fourier transform and an inverse Fourier
transform successively on both sides of the equation:
Uelec = F 1{F{Qgrid}⇤ · F{V gridelec }}. (2.8)
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The FFT algorithm is utilized to efficiently calculate both the Fourier transform and the
inverse Fourier transform operations. In contrast to the naive algorithm which requires
O((NxNyNz)2) number of operations to calculate the cross correlation function, the FFT
algorithm only needs O((NxNyNz) log(NxNyNz)) number of operations. Similarly, the
FFT algorithm can also be used to calculate the van der Waals interaction energy in Eq.
2.7 Although the FFT algorithm can significantly accelerate the calculation of cross cor-
relation functions, one cross correlation function can only provide interaction energies be-
tween proteins and ligands as the ligand translates within the binding pocket with a fixed
conformation and a fixed orientation. In other words, FFTs only accelerate the search of
the ligand translational space. However, in protein-ligand docking where at least the ligand
is flexible, the interaction energies need to be calculated for the ligand’s different confor-
mations and orientations, in addition to different positions. Therefore, multiple FFTs, each
for one particular conformation and orientation of the ligand, are needed in protein-ligand
docking. To accelerate this calculation, multiple FFTs are run on GPUs in batch mode to
take advantage of the parallel computing power of GPUs[35].
2.2.3 Parallel MD-based simulated annealing with GPUs
As the protein-ligand interaction energy landscapes have local minimums and the MD-
based simulated annealing is a heuristic search method, multiple trials of MD-based simu-
lated annealing have to be employed to help search for the lowest energy pose. As the num-
ber of trials increases, the docking accuracy improves. In addition, in a typical application,
CDOCKER needs to dock a large number of ligands with a protein. Therefore, accelerat-
ing multiple trials of MD-based simulated annealing can help CDOCKER to dock a large
number of ligands in a limited time while maintaining docking accuracy. Because trials of
MD-based simulated annealing are independent with each other, one way to accelerate the
calculation is to run them in parallel with multiple processors. With previous implemen-
tation of CDOCKER, multiple trials of MD-based simulated annealing can already be run
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in parallel with multiple CPUs. Here we introduce a new feature of CDOCKER to enable
it to run multiple trials of MD-based simulated annealing simultaneously on GPUs which
have been widely used to accelerate other MD simulations.
As there are already implementations of MD engines running on GPUs, instead of
writing a new MD engine specifically for running multiple trials of MD-based simulation
annealing on GPUs, we adopt the existing GPU-enabled MD engine in OpenMM[36]. To
utilize the MD engine from OpenMM for our purpose, we make a customized system
consisting of multiple copies of a ligand and one copy of the potential grids of the protein.
Atoms in each copy of the ligand interacts with ligand atoms in the same copy and the
potential grids, but do not interact with atoms in all other copies of ligands. Therefore,
although the system includes multiple copies of the ligand, these copies of ligands are
independent with each other and the dynamics of each copy of ligand is the same as if there
is just one copy of ligands. Running one trial of MD-based simulated annealing with this
customized system is equivalent to running multiple trails of simulated annealing for the
ligand.
This approach of running multiple trials of MD-based simulated annealing on GPUs
is also applicable to flexible CDOCKER [9], in which both ligand atoms and protein side
chain atoms of the amino acids near the binding pocket are flexible. In this case, the
customized OpenMM[36] system includes not only multiple copies of ligand atoms but
also multiple copies of protein side chain atoms that are flexible. Similarly, each copy of
flexible protein side chain atoms only interact with itself and the corresponding copy of
ligand atoms and do not interact with other copies of either ligand atoms or flexible protein
atoms.
2.2.4 Benchmark dataset
Two sets of protein-ligand complexes, the Astex diverse set[37] and the SB2012 set[38],
are used as benchmark datasets to test protein-ligand docking methods in this study. The
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Astex diverse set contains 85 diverse high-resolution protein-ligand complexes and has
been widely used for benchmarking different protein-ligand docking methods[37]. In this
study, 70 of the 85 protein-ligand complexes that do not include cofactors are used. Com-
pared to the Astex diverse set, the SB2012 set[38] is a much larger set of protein-ligand
complexes. It contains 1043 protein-ligand complexes, out of which the 1003 complexes
that do not have cofactors and can be typed using CGenFF [39] are used in this study. The
1003 protein-ligand complexes from the SB2012 set include 69 out of 70 complexes from
the Astex diverse set.
2.3 Results
2.3.1 Fast Fourier transform docking
2.3.1.1 Energy calculation acceleration with FFTs and GPUs
When a ligand has a fixed conformation and a fixed orientation, its interaction energy with
a protein as the ligand translates on grid points can be represented as cross correlation
functions between grids and both FFTs and GPUs are used to accelerate the calculation of
these cross correlation functions. To see the extent to which FFTs and GPUs can accelerate
the calculation, we applied the FFT approach to a test example utilizing the protein-ligand
complex 1G9V(PDB ID). The ligand in 1G9V has dimensions of 5.8A˚⇥14.5A˚⇥8.5A˚ in the
X , Y , and Z directions, respectively. With a grid spacing distance of 0.5A˚, the ligand grid
has 13⇥ 30⇥ 18 points. The binding pocket is defined as a cubic box with a dimension of
29.5A˚, and the protein potential grid with the same grid spacing distance as the ligand grid
has 60 grid points in all three directions. Therefore, within the binding pocket, the ligand
has 59, 220 = 47⇥ 30⇥ 42 possible positions. The interaction energy between the protein
and the ligand for all possible positions of the ligand is calculated using three methods: the
naive method which explicitly calculates the interaction energy for each position on a CPU,
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Table 2.2: Wall time used by the three methods: the naive method
looping through all positions on a CPU, FFTs (CPU), and FFTs (GPU)
to calculate interaction energies between the protein and ligand in
1G9V for the ligand’s 59,220 positions.
Methods Naive(CPUa) FFTs(CPUa) FFTs(GPUb)
Wall time (seconds) 31.20 0.28 0.002c
a The CPU used is the Intel Xeon Processor E5645 2.4GHz
b The GPU used is the NVIDIA GeForce GTX 1080
c Multiple FFTs run in parallel on GPUs in batch mode. The wall time is
calculated as the wall time used to run one batch of FFTs divided by the
batch size which is 100.
FFTs running on a CPU, and FFTs running on a GPU. The wall times used by the three
methods are summarized in Table 2.2. Compared with the naive method, the FFT approach
with CPUs accelerates the calculation by more than 100 times and running FFTs on GPUs
in batch mode further accelerates the calculation by 140 fold. Overall, compared with the
naive method, the speedup of using both FFTs and GPUs is about 15,000 fold.
2.3.1.2 The scoring function’s accuracy in identifying ligand native orientations and
positions.
With the acceleration of both FFTs and GPUs for calculating the interaction energy between
ligands and proteins, it becomes feasible to systematically search ligand orientations and
positions in a reasonable computation time. This, in turn, enables us to investigate the
scoring function’s accuracy in terms of identifying ligand native orientations and positions
given the conformations of both the ligand and the protein. Using the Astex diverse set
and the SB2012 set as test sets, we applied the FFT-based approach with GPUs to rigidly
dock ligands onto proteins using the native conformations of ligands and proteins. To
systematically search the orientation and translation space of ligands, 100,000 randomly
sampled orientations of each ligand are used. For each orientation, the ligand’s translational
space is uniformly covered by a 3 dimensional grid with a grid spacing distance of 0.5A˚.
The docked pose of a ligand is chosen to be the lowest energy pose among the poses with
all possible combinations of sampled orientations and translations.
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Astex diverse set              SB2012
66.34  67.75                66.22   67.63       
num of randomly sample orientations (x105)
accuracy
(A) (B)
Figure 2.2: Docking accuracy of the FFT approach for docking rigid ligands onto rigid
proteins with the native conformations of both ligands and proteins using the Astex diverse
set and the SB2012 set. (A) Docking accuracy increases as the number of randomly sam-
pled orientations increases. The error bars are estimated using 10 independent repeats. (B)
Docking accuracy when 100,000 randomly sampled orientations are used (black) and when
100,000 randomly sampled orientations plus the native orientation are used (grey).
For both test sets, the docking accuracy first increases as the number of randomly sam-
pled ligand orientations increases and reaches a plateau when 100,000 random orienta-
tions are used (Fig. 2.2A). This plateau occurs at a docking accuracy of about 66.34% and
66.22% for the Astex diverse set and the SB2012 set, respectively. (Fig. 2.2B). When the
native orientation is included, in addition to the 100,000 random orientations, the docking
accuracy increases to about 67.75% and 67.63% for the Astex diverse set and the SB2012
set, respectively. (Fig. 2.2B). It is notable that this small difference suggests that the use of
100,000 rotational samples is sufficiently dense to cover the rotational space. The docking
accuracy at the plateau, which is around 68%, represents the accuracy of the CHARMM
force field in identifying the native orientations and positions of ligands assuming the native
conformations of ligands are given. This accuracy should be an upper bound of the accu-
racy of the CHARMM force field in identifying the native ligand poses, which includes the
native conformations in addition to the native orientations and positions. Although the size
of the SB2012 set is more than ten times larger than the Astex diverse set, the results on
the two sets are quite similar. This suggests that the CHARMM force field does not over
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fit a specific set of protein-ligand complexes. This should be the case since the CHARMM
CGenFF force field together with the CHARMM protein force field representing the pro-
tein grid are transferable force fields. This contrasts the anticipated behavior of purely
empirical scoring functions for docking [12, 11, 40, 41, 42, 43], which utilize data sets
of known protein ligand complexes to optimize the parameters of their scoring function.
This suggests that the scope of application of transferable force fields like those used in
CDOCKER should be much broader than that of empirical scoring functions.
We note that the above FFT-based rigid ligand, rigid receptor docking approach could
be generalized to permit ligand conformational space to be sampled. This would involve
first sampling a suitable ensemble of ligand conformations [44] and then carrying out the
rotational/translational sampling to identify the lowest energy conformation using GPU-
accelerated FFTs. This protocol can readily be implemented using CHARMM scripting
language [45]. However, we instead pursue in the following integration of ligand (and pos-
sibly receptor side chain) sampling into an MD simulated annealing scheme as employed
in CDOCKER [7] and Flexible CDOCKER [9].
2.3.2 Parallel MD-based simulated annealing with GPUs.
2.3.2.1 Speedup of parallel MD-based simulated annealing with GPUs compared
with the original CDOCKER with CPUs.
Compared with the original CDOCKER running serially on CPUs, the speedup of the paral-
lel MD-based simulated annealing with GPUs is shown in Table 2.3. For the protein-ligand
pairs in the Astex diverse set, when 100 and 500 docking trials are used, the average wall
time used by the original CDOCKER with CPUs are 338.4 and 1692.0 seconds, respec-
tively. In contrast, the average wall time used by the parallel MD-based simulated anneal-
ing with GPUs are 30.8 and 85.5 seconds, respectively, which is about 10 fold and 20 fold
faster. The speedup becomes even larger when the number of trials used increases, because
the wall time used by the original CDOCKER on CPUs is proportional to the number of
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trials.
Table 2.3: Speedup of parallel MD-based simulated annealing with GPUs compared with
the original CDOCKER with CPUs on the Astex diverse set.
CDOCKER with CPUs CDOCKER with parallel MD-basedsimulated annealing with GPUs
accuracya 0.623 ± 0.023 0.631 ± 0.029
wall timeb (seconds) 338.4 30.8
wall timec (seconds) 1692.0 85.5
a The accuracy when 100 trials are used. The ligand native conformation is used as the
starting conformation.
b The wall time used when 100 trials are used.
c The wall time used when 500 trials are used.
2.3.2.2 Comparison with other protein-ligand docking programs.
The accelerated CDOCKER is compared with three other widely used protein-ligand dock-
ing programs including Autodock, Autodock Vina, and DOCK. The re-docking results on
the Astex diverse set and the SB2012 set are shown in Table 2.4 and Table 2.5, respectively.
With the acceleration achieved by the parallel MD-based simulated annealing with GPUs in
CDOCKER, the average wall time required by CDOCKER for docking one protein-ligand
complex is either faster than or on par with other programs. For CDOCKER, Autodock,
and Autodock Vina, their docking accuracies depend on whether ligands’ native or random
conformations are used as starting conformations. Staring with ligands’ native conforma-
tions makes the conformational search easier and the docking accuracies much higher than
their docking accuracies which are corresponding to using ligands’ random conformations
as starting conformations. Because the DOCK program uses the “anchor and grow” search
method[13], its accuracy does not depend on the starting conformations of ligands.
Based on the result from the Astex diverse set, when ligand random conformations
are used as starting conformations, DOCK and Autodock Vina have similar and highest
docking accuracy. Autodock has the lowest docking accuracy and CDOCKER is in be-
tween. Increasing the parameter that controls the searching exhaustiveness in Autodock
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Table 2.4: Docking accuracy of multiple protein-ligand docking programs on the Astex
diverse set.
CDOCKERd Autodock Autodock Autodock DOCKv4.2.6 Vinae Vinaf v6.7
accuracy (nativea) 0.664 0.600 0.701 0.710(± 0.022) (± 0.020) (±0.019) (± 0.009) 0.639
accuracy (randomb) 0.537 0.530 0.633 0.623 (± 0.016)(±0.021) (±0.029) (±0.014) (±0.011)
wall timec 85.5 279.6 82.3 202.9 50.0
a Ligand native conformations are used as starting conformations.
b Ligand random conformations are used as starting conformations.
c CDOCKER is run on a GPU (NVIDIA GeForce GTX 980). All the other docking
programs use one CPU (Intel Xeon Processor E5645 2.4GHz).
d 500 trials are used in CDOCKER.
e exhaustiveness = 8.
f exhaustiveness = 20.
Vina from 8 to 20 proportionally increases the running time, but it does not change its
docking accuracy significantly. Compared with the results on the Astex diverse set (Ta-
ble 2.4), the relative performance of the protein-ligand docking programs for the SB2012
set is the same in terms of docking accuracy (Table 2.5). However, for all the programs,
the docking accuracies are significantly lower on the SB2012 set (Table 2.5) than that on
the Astex diverse set. Although the Astex diverse set contains a diverse set of protein-
ligand complexes, the number of protein-ligand complexes in the set is relatively small.
Because the SB2012 dataset contains more than an order of magnitude more protein-ligand
complexes, the performance on the SB2012 set should be a more objective measure of the
protein-ligand docking programs’ docking accuracies. The lower docking accuracies on the
SB2012 set for all the tested protein-ligand docking programs can be attributed to either
search algorithms or scoring functions or both. In the case of Autodock Vina, increasing
the exhaustiveness from 8 to 20 only slightly improves its docking accuracy, which im-
plies that the empirical scoring function used in Autodock Vina might over fit, to some
extent, the protein-ligand complexes that are used to parameterize its scoring function. In
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Table 2.5: Docking accuracy of multiple protein-ligand docking programs on the SB2012
set.
CDOCKERc Autodock Autodock Autodock DOCKv4.2.6 Vinad Vinae v6.7
accuracy(nativea) 0.569 0.477 0.631 0.642(± 0.006) (± 0.009) (±0.004) (± 0.005) 0.553
accuracy (randomb) 0.429 0.418 0.532 0.547 (±0.005)(± 0.007) (±0.004) (±0.004) (±0.004)
a Ligand native conformations are used as starting conformations.
b Ligand random conformations are used as starting conformations.
c 500 trials are used in CDOCKER.
d exhaustiveness = 8.
e exhaustiveness = 20.
the cases of both CDOCKER and DOCK, because their scoring functions are based on MD
force fields that are more physically realistic, their lower performance on the SB2012 set
are more likely because of search algorithms. The docking accuracies of both Autodock
Vina and DOCK reported in this study are quite different from those reported in previous
studies [12, 13, 46]. It is because of the fact, as shown in this study, that the docking
accuracy of a protein-ligand docking program can vary significantly depending on ligand
starting conformations and benchmark datasets.
2.4 Conclusion and Discussion
Two new features — fast Fourier transform (FFT) docking and parallel MD-based sim-
ulated annealing — are implemented and added to the protein-ligand docking program
CDOCKER in CHARMM. The FFT docking not only utilizes the acceleration provided
by FFTs but also employs the parallel computing power of GPUs. Overall, FFT dock-
ing with GPUs accelerates the search of ligand’s positions and orientations by as much as
15,000 fold. With the significant speedup achieved by FFT docking with GPUs, it becomes
practical to almost exhaustively search the translation and rotation space of ligands when
docking rigid ligands into binding pockets. Although FFT docking alone can not solve
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the protein-ligand problem in which ligands are flexible, the FFT docking can be used to
quickly to calculate an upper bound of the docking accuracy that can be achieved by a
scoring function. This in turn can provide insights into the problems of current scoring
functions and help improve the scoring function. In addition, because FFT docking with
GPUs can efficiently calculate protein ligand interaction energies for an almost exhaustive
list of positions and orientations given a ligand conformation, FFT docking could also be
used to explicitly calculate the partition function corresponding to ligands’ translational
and rotational space, which can be combined with existing scoring functions in protein-
ligand docking to more accurately estimate protein-ligand binding affinities. A similar idea
has been investigated by Nguyen et. al.[47] The parallel MD-based simulated annealing
with GPUs enables CDOCKER to run about 20 times faster when 500 trials of simulated
annealing are used. The speedup becomes even larger when more trials of simulated an-
nealing are employed. With the acceleration, the speed of CDOCKER is on par with or
faster than several other popular protein-ligand docking programs tested in this study.
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CHAPTER 3
Free Energy Calculation
Ding, Xinqiang, Jonah Z. Vilseck, Ryan L. Hayes, and Charles L. Brooks III. “Gibbs
sampler-based  -dynamics and Rao-Blackwell estimator for alchemical free energy cal-
culation.” Journal of chemical theory and computation 13, no. 6 (2017): 2501-2510.
3.1 Background
Free energy calculation is fundamental for understanding many important biophysical pro-
cesses, such as protein conformational changes, protein-protein interactions, and protein-
ligand binding processes.[4, 48] Calculating protein-ligand binding free energy has im-
portant applications in drug discovery, especially in the lead compound generation and
optimization stages.[6, 49, 50] These stages only require calculating protein-ligand rela-
tive binding free energy, which has been shown to be easier than calculating protein-ligand
absolute binding free energy.[6, 49]
One widely used methodology for calculating protein-ligand relative binding free en-
ergy is the alchemical free energy approach.[6, 49, 50] This approach utilizes the thermody-
namic cycle shown in Figure 3.1.[48] This thermodynamic cycle specifies that  GbindingL0!L1 =
 GbindingL1    GbindingL0 =  GboundL0!L1    GunboundL0!L1 . In order to calculate the relative binding
free energy between ligand L0 and L1 with receptor R, i.e,   G
binding
L0!L1 , the alchemical
free energy method calculates  GunboundL0!L1 and  G
bound
L0!L1 by employing alchemical trans-
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Figure 3.1: The thermodynamic cycle used for calculating a relative binding free energy
between ligand L0 and L1 with a receptor R.
formations morphing ligand L0 into ligand L1 in both unbound and bound environments,
respectively.
3.2 Previous methods
Several alchemical free energy calculation methods have been developed over the last sev-
eral decades, such as free energy perturbation[51, 52], thermodynamic integration[48, 53],
enveloping distribution sampling[54, 55] and  -dynamics[56, 57, 58, 59, 60, 61, 62].  -
dynamics is a generalized ensemble method in which the alchemical transformation vari-
able   is a continuous variable ranging from 0 to 1, with   = 0, 0 <   < 1, and   = 1
corresponding to the ligand being in L0 state, intermediate hybrid states, and L1 state,
respectively. The potential energy corresponding to   is
V ( , {xi}1i=0, X) = (1   )V0(x0, X) +  
 
V1(x1, X) +G
b
1
 
+ Venv(X), (3.1)
where X , x0 and x1 are atomic coordinates associated with the environment, the ligand L0
and the ligand L1, respectively. Vi(xi, X) is the potential energy between ligand Li and
the environment and Venv(X) is the potential energy of the environment. Gb1 is a biasing
potential to ensure that the two physical states, corresponding to   = 0 and   = 1, are both
sampled in the simulation. The biasing potential Gb1 is determined iteratively by running
multiple short simulations[59, 60, 63, 64]. The dynamics of the system ( , {xi}1i=0, X) is
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generated from the extended Hamiltonian:
H( , {xi}1i=0, X) = Tx,X + T  + V ( , {xi}1i=0, X) (3.2)
where Tx,X and T  are the kinetic energy associated with coordinates ({x}1i=0, X) and
 , respectively. The free energy difference between ligand L0 and L1, with the biasing
potential Gb1, is
 G =    1 ln P (  = 1)
P (  = 0)
, (3.3)
where   is the inverse temperature; P (  = 0) and P (  = 1) are probability denisties of
  at points 0 and 1, respectively. In practice, this free energy difference  G is estimated
using the following empirical estimator based on the trajectory of  :
 Gˆ =    1 ln P (  >  cutoff)
P (  < 1   cutoff) , (3.4)
where  cutoff (0 <  cutoff < 1) is a cutoff value which is chosen to be close to 1.[59]
Although the empirical estimator is straightforward to evaluate based on the   trajec-
tory, it is not necessarily optimal. One issue is that the empirical estimator is systematically
biased as it uses P (  < 1    cutoff) and P (  >  cutoff) to approximate P (  = 0) and
P (  = 1), respectively. Additionally, the bias depends on the cutoff value  cutoff, which is
chosen empirically and is difficult to quantify as it may vary among different systems.
In the current work, we present a novel form of  -dynamics called the Gibbs sam-
pler based  -dynamics (GSLD) with the Rao-Blackwell estimator (RBE). The Gibbs sam-
pler framework for calculating free energy differences between two ligands was first sug-
gested by Chodera and Shirts[65]. In their work,   was treated as a discrete variable and
MBAR[66] was used to estimate the free energy change. In this study, we show that GSLD
and RBE can treat   as either a discrete variable or a continuous variable when calculating
free energy differences between two ligands. When   is treated as a continuous variable,
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GSLD and RBE can be generalized to simultaneously calculate free energies of multiple
ligands in one simulation, as in the generalization of  -dynamics[59]. We explore these
new methods through applications to three model systems in this paper. This paper is orga-
nized as follows. In section 2, we describe GSLD and its generalization to multiple ligands.
Then we introduce the RBE and show that the MBAR/UWHAM equations [66, 67, 68] can
be derived from the RBE. In section 3, we give detailed setup information for the setup and
simulation of the three systems with which we tested the methods. Our results for these
three systems are presented in section 4. We conclude with a discussion of how the GSLD
and RBE can be used for other applications.
3.3 Gibbs sampler based  -dynamics
As a generalized ensemble method, GSLD samples from the joint distribution of   and the
atomic coordinates of the system using the Gibbs sampler. In this section, we first briefly
introduce the Gibbs sampler. We then use the Gibbs sampler to formulate pairwise GSLD.
We conclude by showing how the GSLD can be generalized to work for multiple ligands.
3.3.1 The Gibbs sampler.
The Gibbs sampler, which is widely used in both statistics and machine learning, is a
Markov ChainMonte Carlo (MCMC)method for sampling frommultivariate distributions[69,
70]. To sample (X, Y ) from the joint distribution: (X, Y ) ⇠ P (X, Y ), the Gibbs sampler
generates a Markov chain of states {(Xt, Yt), t = 0, 1, 2, ..., N} using the following proce-
dure:
• Step 0: initialize the starting state (X0, Y0).
• Step t: sample from the conditional distribution
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– Updating X: given the state (Xt 1, Yt 1) from step t   1, sample Xt from the condi-
tional distribution of Xt ⇠ P (Xt|Yt 1).
– Updating Y: given Xt from the above update step, sample Yt from the conditional
distribution of Yt ⇠ P (Yt|Xt). The resulting sample (Xt, Yt) is the state for step t.
Because the above procedure satisfies the detailed balance condition with respect to the
joint distribution: (X, Y ) ⇠ P (X, Y ), the sampled states {(Xt, Yt), t = 0, 1, 2, ..., N}
converge to the joint distribution.[69, 70] The update steps require sampling from both
conditional distributions: Xt ⇠ P (Xt|Yt 1) and Yt ⇠ P (Yt|Xt). If direct sampling from
the conditional distribution is possible, independent samples can be directly drawn using
numerical pseudo-random number generators. Otherwise, samples can be drawn using
other Monte Carlo methods or Hamiltonian dynamics, as long as the method satisfies the
detailed balance condition with respect to the corresponding conditional distribution.[70,
71] This property of the Gibbs sampler makes it quite flexible on choosing appropriate
sampling methods based on the conditional distributions.
3.3.2 Pairwise GSLD.
Pairwise GSLD calculates the free energy difference between two ligands: ligand L0 and
ligand L1. In pairwise GSLD,   can be treated as either a continuous variable or a discrete
variable.
Continuous  . When   is treated as a continuous variable, pairwise GSLD samples
from the joint distribution of ( , {xi}1i=0, X):
P ( , x0, x1, X) =
exp(  
h
(1   )V0(x0, X) +  
 
V1(x1, X) +Gb1
 
+ Venv(X)
i
)
Z
, (3.5)
where Z is the partition function of the generalized ensemble and Gb1 is a biasing poten-
tial. Gb1 is determined automatically in the current simulations using a Wang-Landau like
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algorithm[72] which is described in 3.7.1. The Gibbs sampler for sampling from the above
joint distribution is as follows:
• Step 0: initialize the starting state ( 0, {x0i }1i=0, X0).
• Step t: sample from the conditional distributions:
– Updating ({xi}1i=0, X): given the state ( t 1, {xt 1i }1i=0, X t 1) from step t 1, sample
({xti}1i=0, X t) from the conditional distribution: P ({xti}1i=0, X t| t 1) / exp(  
h
(1 
 t 1)V0(xt0, X
t) +  t 1
 
V1(xt1, X
t) + Gb1
 
+ Venv(X t)
i
), which is the canonical en-
semble distribution at the inverse temperature  . A sample can be drawn from this
distribution using molecular dynamics simulation.
– Updating  : given the atomic coordinates ({xti}1i=0, X t) sampled from the above up-
date step, sample  t directly from the conditional distribution P ( t|{xti}1i=0, X t) us-
ing numerical pseudo-random number generator. The conditional distribution P ( t|
{xti}1i=0, X t) is:
P ( t|{xti}1i=0, X t)
=
exp(  
h
(1   t)V0(xt0, X t) +  t
 
V1(xt1, X
t) +Gb1
 
+ Venv(X t)
i
)R 1
0 exp(  
h
(1   t)V0(xt0, X t) +  t
 
V1(xt1, X
t) +Gb1
 
+ Venv(X t)
i
)d 
=
  · ( V t0!1 +Gb1) exp(  t ·   · [ V t0!1 +Gb1])
1  exp(   · [ V t0!1 +Gb1])
(0   t  1),
(3.6)
where  V t0!1 = V1(xt1, X t)   V0(xt0, X t). This is an exponential distribution of  t
restricted on the interval of [0, 1]. Therefore, sampling  t directly from this distribution
can be done using the inverse transformation method:
 t =   1
  · ( V t0!1 +Gb1)
ln
h
1  [ 1  e ·( V t0!1+Gb1) ] · u
i
(3.7)
where u is a random sample from the uniform distribution on [0, 1]. The resulting
sample ( t, {xti}1i=0, X t) is the state for step t.
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Discrete  . When   is a discrete variable specified by the set {l1, l2, ...lM}, GSLD
samples from the joint distribution
P (  = lj, x0, x1, X) / exp(  
h
V0(x0, X, 1  lj)+V1(x1, X, lj)+Gbj+Venv(X)
i
), (3.8)
where Gbj is the biasing potential added to the state corresponding to   = lj . Sampling
from this distribution is done in the same way as the case where   is continuous except that
the conditional distribution P ( t|{xti}1i=0, X t) becomes a multinomial distribution:
P ( t = lj|{xti}1i=0, X t)
=
exp(  
h
V0(xt0, X
t, 1  lj) + V1(xt1, X t, lj) +Gbj
i
)PM
k=1 exp(  
h
V0(xt0, X
t, 1  lk) + V1(xt1, X t, lk) +Gbk)
i
)
(3.9)
from which samples can also be drawn directly using numerical methods. The biasing
potentials Gbj are determined similarly as the case when   is continuous. We note that
equation 3.9 is similar to the distribution calculated using the infinite swap limit in replica
exchange methods.[73, 74, 75, 76]
The advantage of using   as a discrete variable is that the pairwise GSLD still works
when the potential energy Vi(xi, X, ) is   dependent, such as when a soft-core Lennard-
Jones potential[77] is employed to facilitate sampling. When   is continuous, using  
dependent Vi(xi, X, ) will make the normalization constant of the conditional distribution
P ( |{xi}1i=0, X) not analytically integrable and prevent direct sampling from the condi-
tional distribution P ( |{xi}1i=0, X). However, as shown below, the advantage of using  
as a continuous variable is that the GSLD can be generalized for multiple ligands.
3.3.3 Generalizing GSLD for multiple ligands.
Like  -dynamics, GSLD can be generalized to calculate the free energies for multiple lig-
ands in one simulation. Assuming there are n ligands, the fraction of the ith ligand in the
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hybrid state is represented by  i, for i = 1, 2, ..., n. The hybrid state is specified by the
value of ( 1, 2, ..., n) which satisfies the conditions
Pn
i=1  i = 1 and 0   i  1, i =
1, 2, ..., n. The hybrid state’s potential energy is defined as: V ({ i}ni=1, {xi}ni=1, X) =Pn
i=1  i(Vi(xi, X) +G
b
i) + Venv(X), where xi and X are atomic coordinates associated
with the ith ligand and environment, respectively; Gbi is the biasing potential added for
the ith ligand and can be determined similarly as in the pairwise GSLD. Sampling from the
generalized ensemble distribution: P ({ i}ni=1, {xi}ni=1, X) / exp(   ·V ({ i}ni=1, {xi}ni=1,
X)) can be done using the following Gibbs sampler procedure:
• Step 0: initialize the starting state ({ 0i }ni=1, {x0i }ni=1, X0).
• Step t: sample from the conditional distributions.
– Updating ({xi}ni=1, X): given the state ({ t 1i }ni=1, {xt 1i }ni=1, X t 1) from step t  
1, sample ({xti}ni=1, X t) from the conditional distribution P ({xti}ni=1, X t|{ t 1i }ni=1)
using molecular dynamics simulation.
– Updating { i}ni=1: given the sample ({xti}ni=1, X t) from the above update step, the
conditional distribution of { ti}ni=1 in the set S = {( 1, ..., n) |
Pn
i=1  i = 1 and  i  
0, i = 1, ...n} is given by
P ({ ti}ni=1|{xti}ni=1, X t) =
exp(  
hPn
i=1  
t
i [ Vi(x
t
i, X
t) +Gbi ] + Venv(X
t)
i
)
Z
,
(3.10)
where
Z =
Z
S
exp(  
h nX
i=1
 ti [ Vi(x
t
i, X
t) +Gbi ] + Venv(X
t)
i
)dmS( )
= e  Venv(X
t)
nX
i=1
e
  
h
Vi(xti,X
t)+Gbi
i
 n 1
Q
j 6=i (
h
Vj(xtj, X
t) +Gbj
i
 
h
Vi(xti, X
t) +Gbi
i
)
,
(3.11)
and dmS( ) is the infinitesimal volume element of the simplex S. Because
Pn
i=1  
t
i =
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1, the conditional distribution P ({ ti}ni=1|{xti}ni=1, X t) has only n  1 degrees of free-
dom. Sampling from this conditional distribution is equivalent to sampling from the
n  1 dimensional distribution:
P ({ ti}n 1i=1 |{xti}ni=1, X t) /
exp(  
h n 1X
i=1
 i [ Vi(x
t
i, X
t) +Gbi   Vn(xtn, X t) Gbn ]
i
),
(3.12)
where 0  Pn 1i=1  ti  1, and  ti   0. The environment atom energy term, Venv(X t),
does not appear in equation (3.12) because it is part of both the numerator and denom-
inator of equation (3.10) and can be canceled out as a constant when ({xti}ni=1, X t)
is fixed. Sampling from this n   1 dimensional distribution P ({ ti}n 1i=1 |{xti}ni=1, X t)
is done using the rejection method. In the rejection method, each { ti}n 1i=1 is sam-
pled independently from the distribution: P ( ti) / exp(   i
h
Vi(xti, X
t) + Gbi  
Vn(xtn, X
t)   Gbn
i
), where 0   ti  1. If the sample { ti}n 1i=1 satisfies the condi-
tion 0  Pn 1i=1  ti  1, it is accepted, otherwise the sample { ti}n 1i=1 is rejected. This
procedure is repeated until a sample { ti}n 1i=1 is accepted. Set  tn = 1  
Pn 1
j=1  
t
j and
the resulting sample ({ ti}ni=1, {xti}ni=1, X t) is the state for step t.
3.4 Rao-Blackwell estimators
3.4.1 Rao-Blackwell estimators for  -dynamics
Although the empirical estimator used in  -dynamics can also be utilized in GSLD to es-
timate the free energy, it is not an optimal estimator and may contain a system dependent
bias. RBE is introduced here to eliminate these potential issues. RBE is the estimator de-
rived by applying the Rao-Blackwellization transformation to the empirical estimator. Rao-
Blackwellization is a statistical method, inspired by the Rao-Blackwell theorem[78, 79], to
transform a crude estimator into a better estimator that has smaller mean squared error for
31
estimating the quantity of interest[80]. Specifically, if  (Z) is an estimator of an unknown
parameter ✓ and T (Z) is a sufficient statistics for the parameter ✓, the Rao-Blackwellized
estimator of the estimator  (Z) is the conditional expected value E( (Z)|T (Z))[78, 79].
For pairwise GSLD with continuous  , the quantity of interest is the free energy G =
   1 ln ⇥P (  = 1)/P (  = 0)⇤. The values of both P (  = 1) and P (  = 0) are viewed
unknown parameters. To estimate G, i.e., P (  = 1) and P (  = 0), the empirical estima-
tor approximates P (  = 1) and P (  = 0) directly by calculating the fraction of  s which
are close to 1 and 0, respectively, based on the   trajectory. In contrast, the RBE ignores
the   trajectory and only uses the atomic coordinate trajectory. Because the coordinate
({xi}1i=0, X) is a sufficient statistics for the parameters P (  = 1) and P (  = 0), applying
the Rao-Blackwellization yields the RBE estimators as P (  = 1) = E{{xi}1i=0,X}
⇥
P (  =
1|{xi}1i=0, X)
⇤
and P (  = 0) = E{{xi}1i=0,X}
⇥
P (  = 0|{xi}1i=0, X)
⇤
. Therefore, RBE uses
the following formula to estimate the free energy  G:
 GRBE =    1 ln P (  = 1)
P (  = 0)
=    1 ln E{{xi}1i=0,X}
⇥
P (  = 1|{xi}1i=0, X)
⇤
E{{xi}1i=0,X}
⇥
P (  = 0|{xi}1i=0, X)
⇤
=    1 ln 1/N ·
PN
t=0 P (  = 1|{xti}1i=0, X t)
1/N ·PNt=0 P (  = 0|{xti}1i=0, X t)
(3.13)
where
P (  = 1|{xti}1i=0, X t) =
  · ( V t0!1 +Gb1) · exp(   ·
⇥
 V t0!1 +G
b
1
⇤
)
1  exp(   · ⇥ V t0!1 +Gb1⇤)
P (  = 0|{xti}1i=0, X t) =
  · ( V t0!1 +Gb1)
1  exp(   · ⇥ V t0!1 +Gb1⇤) ,
(3.14)
and N is the number of samples.
For the generalized GSLD with multiple ligands, the RBE can be derived similarly. To
estimate the free energy of the ith ligand given by G( i = 1, j 6=i = 0) =    1 lnP ( i =
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1, j 6=i = 0), the RBE uses the following formula:
GRBE( i = 1, j 6=i = 0) =    1 lnP ( i = 1, j 6=i = 0)
=    1 lnE{{xk}nk=1,X}
h
P ( i = 1, j 6=i = 0|{{xk}nk=1, X})
i
=    1 ln
h
1/N ·
NX
t=0
P ( i = 1, j 6=i = 0|{{xk}nk=1, X})
i
=    1 ln
h
1/N ·
NX
t=0
exp(  ⇥Vi(xti, X t) +Gbi⇤)
Z
i
,
(3.15)
where Z is given in equation 3.11 in section 2.1.3.
As shown in the above formulas, the RBE estimator  GRBE does not depend on the
empirical cutoff value of  cutoff. Based on the Rao-Blackwell theorem,  GRBE is an unbi-
ased estimator. In addition, if the samples from GSLD are independent, the mean squared
error of RBE is guaranteed to be smaller than or equal to that of the empirical estimator.
Although the samples from GSLD are usually not truly independent, the advantage of RBE
can often be justified empirically.[81]
3.4.2 Derivation of the MBAR/UWHAM equations using RBE
Although RBE is originally introduced to estimate free energies based on sampling from
GSLD, RBE can also be used when multiple equilibrium states are sampled independently.
When RBE is applied to this case, it generates the MBAR/UWHAM equations[66, 67, 68],
which are widely used in current alchemical free energy methods.
Let us assume there areM equilibrium states with potential energy function of Vi, i =
1, 2, ...,M . Each equilibrium state is sampled independently. The conformations sampled
from state i are represented as xki , k = 1, 2, ..., ni, where ni is the number of conformations
from state i. The total number of conformations is N =
PM
j=1 nj . The free energy of
state i is represented as G⇤i . We use   2 {1, 2, ...,M} as an index variable to represent the
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M equilibrium states, with   = i corresponding to state i. To calculate the free energies
for all the equilibrium states, all the conformations {xki , i = 1, 2, ...,M, k = 1, 2, ..., ni}
are pooled together and viewed as samples from the generalized ensemble P (  = i, x) /
e  [Vi(x)+Gbi ], whereGbi is the biasing energy added to state i to adjust the relative weight of
state i to be proportional to ni, i.e, Gbi needs to satisfy the condition:
Gi = G
⇤
i +G
b
i =    1ln
ni
N
, (3.16)
whereGi is the free energy of state iwith the biasing potential ofGbi andG⇤i is the unbiased
free energy of state i. We note that the biasing potentials Gbi in equation 3.16 are unknown
variables. They are introduced to make the equation 3.16 valid, which is the requirement
for applying the RBE. These unknown biasing potentials Gbi can be calculated after the
values of G⇤i are solved. The RBE for this generalized ensemble is:
Gi =    1lnP (  = i)
=    1ln 1
N
MX
j=1
niX
k=1
P (  = i|xkj )
=    1ln 1
N
MX
j=1
njX
k=1
e  
⇥
Vi(xkj )+G
b
i
⇤
PM
l=1 e
  
⇥
Vl(xkj )+G
b
l
⇤
(3.17)
Combining equation 3.16 with equation 3.17, we have:
G⇤i =    1ln
MX
j=1
njX
k=1
e  
⇥
Vi(xkj )
⇤
PM
l=1 nl · e  
⇥
Vl(xkj ) G⇤l
⇤ (3.18)
which is the same as theMBAR/UWHAM equations[66, 67, 68]. Previously, theMBAR/UWHAM
equations were derived as either a result of the maximum likelihood principle or an un-
binned extension of the weighted histogram analysis method (WHAM).[66, 67, 68] Here
we have shown that the MBAR/UWHAM equations can also be derived using RBE.
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3.5 Applications of GSLD and RBE
3.5.1 System setups and computational details
To illustrate how GSLD works and the advantage of RBE over the empirical estimator typi-
cally used in  -dynamics, we applied GSLD and RBE to three test cases: (a) calculation of
the free energy difference between two states of a harmonic oscillator system, (b) calcula-
tion of the relative hydration free energies of three benzene derivatives, and (c) calculation
of the binding free energy difference between benzene and p-xylene bound to the L99A
mutant of the protein T4 lysozyme[82, 83]. The simulations in these calculations were
run using CHARMM[45] compiled with OpenMM[34]. Each calculation was repeated 10
times. Error bars were calculated as the standard variation of the results from these 10
independent repeats.
3.5.1.1 Harmonic System.
The harmonic system consists of a one dimensional particle that switches between two
states: state 0 and state 1. Each state has a harmonic potential energy. The purpose is to
calculate the free energy difference of the particle when it changes from state 0 to state 1,
i.e,  G = G1   G0. Specifically, state 0 has a potential energy given by 12k0(x   xe0)2,
and state 1 has a potential energy given by 12k1(x   xe1)2. In order to prevent the particle
from moving too far from the equilibrium position, a restraining potential is added for each
state. This restraining potential is not scaled by  . The resulting hybrid potential energy is:
V ( , x0, x1) = (1   ) · 1
2
k0(x0   xe0)2 +   ·
1
2
k1(x1   xe1)2
+
1
2
kenv(|x0|  xeenv)2 {|x0|   xeenv}+
1
2
kenv(|x1|  xeenv)2 {|x1|   xeenv},
where {condition} is equal to 1 if the condition is true, otherwise it is equal to 0. GSLD
is used to sample from the joint distribution of ( , {xi}1i=0) : P ( , {xi}1i=0) / exp(   ·
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V ( , {xi}1i=0)). Given the value of  , sampling the coordinates ({xi}1i=0) is accomplished
by running Langevin dynamics for 1 ps with a step size of 1 fs, temperature of 300 K, and
friction coefficient of 10 ps 1. The total simulation time is 10 ns. The parameters used for
xe0, xe1, xeenv and kenv are  2.0 A˚ , 2.0 A˚ , 4.0 A˚ , and 2.5 kcal/mol · A˚ 2, respectively. Two
variations of the model system that correspond to setting different values for k0 and k1 are
used: a symmetrical system with k0 = k1 = 0.75 kcal/mol · A˚ 2, and an asymmetrical
system with k0 = 0.75 kcal/mol · A˚ 2 and k1 = 0.075 kcal/mol · A˚ 2.
3.5.1.2 Relative hydration free energies for three benzene derivatives.
Relative hydration free energies for three benzene derivatives: benzene, phenol, and ben-
zaldehyde were calculated from the difference between alchemical free energy changes
computed in vacuum and in water. The topology and parameter files for the hybrid ligand
were generated using MATCH[84] and in-house developed scripts based on the CHARMM
General Force Field (CGenFF)[39]. The simulation in water was done in a water box
consisting of 800 TIP3P[85] water molecules with cubic periodic boundary conditions.
The water box had a size of 30.0 A˚ ⇥ 30.0 A˚ ⇥ 30.0 A˚. A nonbonded cutoff of 14
A˚ was used, and the van der Waals switching function and electrostatic force switching
function [86] were used between 12 A˚ and 14 A˚. Sampling from the conditional distri-
bution P (x,X| ) was accomplished by running Langevin dynamics at 298.15 K for 0.2
ps. The time step size was 2 fs and the friction coefficient was 10 ps 1. The length of
all bonds involving hydrogen atoms was fixed during the simulation using the SHAKE
algorithm[87]. The three relative hydration free energies were first calculated by three in-
dependent pairwise GSLDs. Then they were calculated simultaneously using the general-
ized GSLD for multiple ligands. For comparison, the three relative hydration free energies
were also calculated using the FEP/MBAR method, in which 11 states corresponding to
  = 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1 were used.
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3.5.1.3 Relative binding free energy between benzene and p-xylene with
T4 lysozyme.
The L99A mutant of T4 lysozyme has been a model protein system for testing free energy
calculation methods[88, 89, 90]. It has experimental binding free energy data for a series
of benzene derivatives including benzene and p-xylene. [82, 83] The relative binding free
energy between benzene and p-xylene was calculated using the difference between the al-
chemical free energy change in water and in the protein environment. The alchemical free
energy change in water was calculated using pairwise GSLD with continuous  . Calcu-
lating the alchemical free energy in the protein environment is challenging, even though
the binding site of T4 lysozyme is a relatively simple non-polar pocket and the alchem-
ical change from benzene to p-xylene is small. This challenge arises from the fact that
T4 lysozyme has a conformational change for the side-chain dihedral angle   (N-CA-CB-
CG1) of residue Val111, which accompanies the alchemical transformation from benzene
to p-xylene.[88] When T4 lysozyme binds with benzene (PDB ID: 181L), the dihedral
angle stays in the trans conformation (  ⇡  180 ). When it binds with p-xylene (PDB
ID: 187L), the dihedral angle changes into the gauche conformation (  ⇡  60 ). Fail-
ing to sample these two relevant conformations in a free energy calculation would cause
a quasi-nonergodicity problem, i.e, the calculated free energy will depend on which con-
formation is used as the starting conformation.[88, 90] To address the problem, several
methods have been developed. These methods include enhanced sampling methods such
as the 2-dimensional replica exchange method (REM)[89] and the free energy perturba-
tion/replica exchange with solute tempering (FEP/REST) method [90], and the potential of
mean force (PMF) method, which was first introduced by Tobias and Brooks for address-
ing a similar problem in 1989[91] and rediscovered as the “confine-and-release” method by
Mobley et al. in 2007.[88] Here we combined the PMF method with GSLD to calculate the
alchemical free energy changes between benzene and p-xylene in the protein environment.
To make our computational protocol clear, we reformulated the PMF method[91, 88]
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using conditional probability as shown in 3.7.2. The free energy change  G( ⇤) was cal-
culated using pairwise GSLD with a harmonic restraint potential on   to keep it near  ⇤
during the pairwise GSLD simulation. The force constant of the harmonic restraint poten-
tial was 1195.3 kcal/mol ·radius 2. In our calculations, we chose  ⇤ to be 180  and 60 ,
although the final calculated result G did not depend on the choice of  ⇤. In the pairwise
GSLD,   was chosen to be a discrete variable specified by the set {l1, l2, ..., l16}.   = l1
corresponds to the physical state that the ligand is benzene and   = l16 corresponds to the
physical state that the ligand is p-xylene. When   was changed from l1 to l16, the ligand
was alchemically transformed from benzene into p-xylene. During the alchemical transfor-
mation, the partial charges on benzene atoms were turned off first. Then the benzene atoms
were transformed into p-xylene atoms before the partial charges on p-xylene atoms were
turned on. A soft-core Lennard-Jones potential was used during the transformation.[92]
The formula used for both electrostatic potential and the soft-core Lennard-Jones poten-
tial is shown in Table S1. The potential energy scaling factors used for each state   = li
are also shown in Table S1. The free energy    1lnP ( ⇤|  = l1) and the free energy
   1lnP ( ⇤|  = l16) were computed by calculating the potential of mean force (PMF)
with respect to   when T4 lysozyme binds with benzene (  = l1) and with p-xylene
(  = l16), respectively. The simulations was run inside a TIP3P water box with a size
of 79.0A˚ ⇥ 56.4A˚ ⇥ 55.4A˚ and rectangular periodic boundary conditions were used. The
water box had 7112 water molecules in total. The CHARMM36 force field[93] was used
for T4 lysozyme and the CHARMM General Force Field (CGenFF)[39] was used for the
ligands. The nonbonded interaction options were the same as that used in the relative hy-
dration free energy calculations.
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Figure 3.2: Results of pairwise GSLD and RBE on harmonic systems. (A)   trajectories for
the symmetrical harmonic system (top) and the asymmetrical harmonic system (bottom);
(B) Free energy estimations for the symmetrical system (top) and the asymmetrical system
(bottom) using the empirical estimators with a cutoff of 0.9 and 0.99 and the Rao-Blackwell
estimator. The horizontal black line is the calculated free energy change using numerical
integration.
3.5.2 Results
3.5.2.1 The harmonic system.
As shown in Figure 3.2(A), GSLD is able to sample the continuous   well for both sym-
metrical and asymmetrical systems. Figure 3.2(B) shows the estimated free energy changes
 G using the Rao-Blackwell estimator and two empirical estimators with cutoff values of
0.9 and 0.99. For the symmetrical system, the true value for the free energy changes is
equal to 0 kcal/mol because of the symmetry. The RBE and the empirical estimator with
cutoff of 0.9 converge to 0 kcal/mol within 2 ns, whereas the empirical estimator with cut-
off of 0.99 needs 10 ns of simulation to converge to 0 kcal/mol. Moreover the RBE has the
smallest variance among the three estimators. For the asymmetrical system, the empirical
estimator with a cutoff of 0.9 converges to  0.41 ± 0.03 kcal/mol and the empirical esti-
mator with a cutoff of 0.99 converges to  0.50 ± 0.06 kcal/mol, whereas the result from
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numerical integration is -0.56 kcal/mol. This shows that the results of empirical estimators
can be biased and the bias depends on the value of the cutoff. Increasing the cutoff value
decreases the estimation bias, but it increases the estimation variance because a higher cut-
off decreases the number of valid samples used by the empirical estimator. In contrast, the
result of RBE converges to  0.56 ± 0.02 kcal/mol, which is closest to the true value and
also has the smallest variance. The detailed numerical results can be found in the Table S2.
Overall, the results suggest that, for this harmonic system, the GSLD is able to extensively
sample the alchemical states and the RBE is better than the empirical estimator in terms of
both bias and variance.
3.5.2.2 Relative hydration free energies for three benzene derivatives.
Results of pairwise GSLD simulations in vacuum and in water are shown in Figure S1 and
Figure 3.3, respectively. The pairwise GSLD is able to sample the alchemical states very
well for both the simulations in vacuum and the simulations in water. For the simulation
in vacuum, the RBE outperforms empirical estimators in terms of both bias and variance,
as in the harmonic system. For the simulation in water, the RBE has a similar variance to
that of the empirical estimators, because samples from the simulation in water are more
correlated than those from the simulations in vacuum. Nevertheless, the RBE is still better
than the empirical estimators in terms of the bias. As shown in Figure 3.3 (B), the empirical
estimator depends on the cutoff. As the cutoff increases from 0.9 to 0.99, the empirical
estimator results move towards to the RBE results. As an example, for the alchemical
change from benzene to benzaldehyde, when the cutoff increases from 0.9 to 0.99, the
empirical estimator result changes from 2.20± 0.08 kcal/mol to 2.60± .08 kcal/mol. The
RBE result is 3.04± 0.09 kcal/mol, which is indistinguishable from the FEP/MBAR result
3.01±0.02 kcal/mol. The detailed numerical values from pairwise GSLD and FEP/MBAR
can be found in the Table S3 and S4.
The simulation results in vacuum and in water from generalized GSLD for multiple
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ligands are shown in Figure S2 and Figure 3.4, respectively. The ternary plots[94] of
( 1, 2, 3) trajectories show that the generalized GSLD is able to explore the hybrid lig-
and configuration space of ( 1, 2, 3): the unit simplex {( 1, 2, 3)|
P3
i=1  i = 1, 0 
 i  1 for i = 1, 2, 3}, in both vacuum and water. In vacuum, the configuration space
( 1, 2, 3) is sampled rather uniformly, while in water, the configuration space is sam-
pled mostly close to the physical states, i.e. the corners of the ternary plot in Figure 3.4.
This difference is because the biasing potential energy used in this study is a linear biasing
potential  iGbi . With the linear biasing potential, the biased free energy landscape over
the configuration space ( 1, 2, 3) in vacuum is almost flat. In water, the correspond-
ing biased free energy landscape is not flat due to the polarization energy of the solvent
interacting with reactant and product states, and the biased free energies of the physical
states is lower than the intermediate non-physical states, which explains why the sampled
( 1, 2, 3) are mostly around the physical states. Based on the trajectory from the gen-
eralized GSLD simulation, the calculated free energy using RBE and empirical estimators
are shown in Figure S2 (B) and Figure 3.4 (B). These results suggests again that, compared
with the empirical estimators, the RBE is a better estimator as it has no bias and a smaller
variance. The detailed numerical results from the generalized GSLD for multiple ligands
is shown in the Table S5.
The calculated relative hydration free energies for the three benzene derivatives using
pairwise GSLD, generalized GSLD for multiple ligands and FEP/MBARmethods are com-
bined in Table 3.1. The results from all three methods agree well with each other. The total
simulation time in water for calculating all three relative hydration free energies is 9 ns for
pairwise GSLD, 3 ns for generalized GSLD for multiple ligands and 33 ns for FEP/MBAR
methods, which suggests the efficacy of the generalized GSLD for multiple ligands.
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Figure 3.3: Results of pairwise GSLD and RBE for calculating solvation free energies.
(A)   trajectories from simulations in water using GSLD for alchemical changes benzene
to phenol (top), benzene to benzaldehyde (middle), and phenol to benzaldehyde (bottom).
(B) Estimated alchemical free energy changes in water using empirical estimators with
different cutoff values and the Rao-Blackwell estimator for alchemical changes benzene to
phenol (top), benzene to benzaldehyde (middle), and phenol to benzaldehyde (bottom).
3.5.2.3 Relative binding free energy of benzene and p-xylene with T4 lysozyme.
The   trajectories from the simulation with T4 lysozyme using pairwise GSLD and the
free energy estimations using RBE are shown in Figure 3.5. For both the case where   is
restricted to the trans conformation ( ⇤ =  180 ) and the case where   is restricted to the
gauche ( ⇤ =  60 ) conformation, the pairwise GSLD is able to sample the alchemical
switching variable  well and the RBE estimations converge in 10 ns of simulation. When  
is restricted to the trans conformation, the estimated free energy converges to 8.40±0.46
kcal/mol. When   is restricted in the gauche conformation, the estimated free energy
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Figure 3.4: Results of generalized GSLD for multiple ligands and RBE for calculating
solvation free energies. (A) Ternary plot of ( 1, 2, 3) sampled using GSLD for multiple
ligands in water. (B) Estimated free energy changes in water for alchemical changes: ben-
zene to benzaldehyde (top) and phenol to benzaldehyde (bottom) using empirical estimator
with different cutoff values and RBE.
Table 3.1: Comparison of Relative Hydration Free Energies (  G in kcal/mol) for The
Three Benzene Derivatives. The total simulation time in water for each method is shown
in parenthesis.
substituents
  Gexp
Pairwise GSLD GSLD for Multiple Ligands FEP/MBAR
change   G(9ns)   G(3ns)   G(33ns)
Benzene! Phenol -5.77  4.46± 0.08  4.53± 0.15  4.46± 0.03
Benzene! Benzaldehyde -3.18  3.11± 0.11  3.22± 0.11  3.13± 0.03
Phenol! Benzaldehyde 2.59 1.39± 0.17 1.31± 0.10 1.34± 0.14
converges to  10.60 ± 0.36 kcal/mol. These two free energy estimations are different by
2.20 kcal/mol because the dihedral angle   is restricted to different conformations. Based
on the PMF method, in order to get the free energy corresponding to the case where   is not
restricted, the restricting free energies (   1 lnP ( ⇤|  = l1) and    1 lnP ( ⇤|  = l16))
need to be considered and used to correct the free energy  G( ⇤) using equation 3.21 in
Appendix B. These corrections are shown in Table 3.2. After the corrections, the estimated
free energy  G is  9.27 ± 0.50 kcal/mol when  ⇤ =  180  and  9.01 ± 0.40 kcal/mol
when  ⇤ =  60 . Therefore, after the corrections, the estimated free energy differences
( G) agree very well within statistical uncertainty. Based on the these corrected values, the
relative binding free energies (  G) are 0.27 ± 0.56 kcal/mol and 0.43 ± 0.46 kcal/mol
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when  ⇤ =  180  and  ⇤ =  60 , respectively. These results are close to the relative
binding free energy from experiment, which is 0.52± 0.22 kcal/mol [82, 83].
Figure 3.5: Results of GSLD and RBE for calculating relative binding free energy be-
tween benzene and p-xylene with T4 lysozyme. (A)   trajectories for simulations with T4
lysozyme using pairwise GSLD for the  ⇤ =  180  (top) and  ⇤ =  60  (bottom); (B)
Free energy estimation using RBE for  ⇤ =  180  (top) and  ⇤ =  60  (bottom).
Table 3.2: Alchemical Free Energy Changes (kcal/mol) Between Benzene and p-Xylene
Binding with T4 Lysozyme Calculated Using Pairwise GSLDwith Corrections from PMFs.
 ⇤  G( ⇤)    1lnP ( ⇤|  = 0)    1lnP ( ⇤|  = 1)  G   G
trans ( ⇤ =  180 )  8.40± 0.46  0.47± 0.01 0.4± 0.03  9.27± 0.50 0.27± 0.56
gauche ( ⇤ =  60 )  10.60± 0.36 1.14± 0.03  0.45± 0.01  9.01± 0.40 0.43± 0.46
The alchemical free energy change G in water is  9.44± 0.06 kcal/mol and the experimental relative binding free
energy  G is 0.52± 0.22 kcal/mol.
3.6 Discussion
Although the GSLD and RBE are applied only for calculating relative hydration free energy
and relative binding free energy in this study, they could also be used for other purposes.
One of the applications would be for calculating the pKa value of protein amino acids by
combining with the constant pH molecular dynamics methods (CPHMD)[95, 63, 96], as
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several CPHMD methods are based on  -dynamics. Furthermore, the GSLD framework
presented here is not limited to alchemical free energy calculations. The   variable could
be replaced by the pH values, which would correspond to pH generalized ensemble simu-
lations. In these cases, we can also derive the corresponding RBE similarly.
In this study, we have presented the formalism for the Gibbs sampler based  -dynamics
(GSLD) and the Rao-Blackwell estimator (RBE) for alchemical free energy calculations.
These methods were successfully demonstrated for three test cases of increasing complex-
ity. The GSLD, a generalized ensemble sampling method, works for the case where   is
a discrete variable and for the case where   is considered to be continuous. When   is
continuous, the GSLD can be generalized to calculate free energies for multiple ligands
simultaneously in one simulation. The RBE not only eliminates the bias problem of the
empirical estimator used in the original  -dynamics, but also has smaller estimation vari-
ance than the empirical estimator. Moreover, we have also shown that the RBE can be
used to derive the MBAR/UWHAM equations, which provides new understanding for the
MBAR/UWHAM method.[66, 67, 68]
3.7 Auxiliary methods
3.7.1 A Wang-Landau like algorithm to automatically determine the
biasing potential Gb1 used in pairwise GSLD when   is continu-
ous.
The purpose of the biasing potentialGb1 used in the pairwise GSLD when   is continuous is
to make the biased free energy landscape over the   space flat, i.e. to make the simulation
spend about equal time at all   values between 0 and 1. In current study, a linear biasing
potential  Gb1 is utilized, because with the linear biasing potential the biased free energy
landscape over   space is quite flat, i.e. the energy barrier between the two physical states
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  = 0 and   = 1 is small enough that the   is well sampled across the interval [0, 1]. If
the linear biasing potential energy cannot make the biased free energy landscape over the
  space flat enough, a quadratic form of biasing potential can be utilized as in Hayes et
al.’s flattening method[64]. The biasing potential Gb1 is determined automatically using the
following Wang-Landau like algorithm:
• Set the initial biasing potential Gb1 = 0 kcal/mol, the decay parameter ↵ such that 0 <
↵ < 1 (↵ = 0.998 in this study), the biasing potential increment  in each step (  = 2.0
kcal/mol in this study) and the number of steps R (R = 3000 in this study). Initialize the
starting state ( 0, {x0i }1i=0, X0).
• For t = 1 to R :
Sample ({xti}1i=0, X t) from the conditional distribution: P ({xti}1i=0, X t| t 1) by running
molecular dynamics simulations and then sample  t from the conditional distribution
P ( t|{xti}1i=0, X t). Set Gb1(t) = Gb1(t  1)+ ( t  0.5) ⇤ (t) and (t) = ↵ ⇤ (t  1).
• The final value of Gb1 from the above step is fixed and used as the biasing potential in
following simulations.
3.7.2 Reformulation of the PMF method using conditional probabil-
ity.
The PMF method requires prior knowledge of which slow degree of freedom is affecting
the free energy calculation. In the context of T4 lysozyme, the slow degree of freedom is the
side-chain dihedral angle N-CA-CB-CG1 ( ) of residue Val111. The joint distribution of
( , ) : P ( , ) is of most interest, as it encapsulates all the relevant information required
to calculate the free energy  G =    1ln(P (  = l16)/P (  = l1)). Based on the chain
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rule of conditional probability, we have the following equations:
P (  =  ⇤,  = l16) = P (  =  ⇤|  = l16)P (  = l16) = P (  = l16|  =  ⇤)P (  =  ⇤)
P (  =  ⇤,  = l1) = P (  =  ⇤|  = l1)P (  = l1) = P (  = l1|  =  ⇤)P (  =  ⇤)
(3.19)
Combining the above two equation gives us:
P (  = l16)
P (  = l1)
=
P (  = l16|  =  ⇤)
P (  = l1|  =  ⇤) ·
P (  =  ⇤|  = l1)
P (  =  ⇤|  = l16) . (3.20)
Therefore, we can calculate the free energy  G as
 G =    1lnP (  = l16)
P (  = l1)
=    1lnP (  = l16|  =  
⇤)
P (  = l1|  =  ⇤)    
 1ln
P (  =  ⇤|  = l1)
P (  =  ⇤|  = l16)
=  G(  =  ⇤) +
⇥    1lnP (  =  ⇤|  = l1)⇤  ⇥    1lnP (  =  ⇤|  = l16)⇤,
(3.21)
where  G(  =  ⇤) is alchemical free energy change when   is fixed at the value  ⇤;
   1lnP (  =  ⇤|  = l1) is the free energy required to restrict the dihedral angle   at the
value  ⇤ when T4 lysozyme binds with benzene, i.e,   = l1;    1lnP (  =  ⇤|  = l16) is
the corresponding free energy required when T4 lysozyme binds with p-xylene, i.e,   = l16.
The above equation holds regardless of the value of  ⇤.
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CHAPTER 4
Protein Engineering
Ding, Xinqiang, Zhengting Zou, and Charles L. Brooks III. “Learning protein stability,
evolution and fitness landscapes with variational auto-encoder models.” submitted.
4.1 Introduction
With the advance of nucleic acid sequencing technology, a large amount of protein se-
quence data has been accumulated in protein sequence databases such as UniProt [97] and
Pfam[98]. For many protein families, many thousands of sequences from different species
are available [98]. These naturally occurring diverse protein sequences, belonging to the
same protein family but functioning in a diverse set of environments, are the result of
mutation and selection occurring in protein evolution. The selection in evolution favors se-
quences which have high fitness and filters out sequences that do not fold correctly or have
low fitness. Therefore, it is expected that the distribution of a protein family’s sequences
observed in present species carries information about the protein family’s properties, such
as structure[99, 100, 101, 102, 103], stability [104, 100, 105, 106, 105, 107], evolution
[100], and fitness [108, 109, 110]. With large numbers of protein sequences becoming
available, several methods have been developed to learn these protein properties using the
sequence data [99, 104, 108, 111, 112, 113, 99].
Of particular interest in this paper are methods that are based on learning probabilis-
tic generative models of a protein family’s sequence distribution [114]. Biologically, a
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protein family is a collection of proteins that share the same evolutionary origin [98]. Pro-
tein sequences belonging to the same protein family can vary among species, as observed
in multiple sequence alignments (MSAs) of protein families in the Pfam database [98].
From a probabilistic point of view, a protein family represented by sequences contain-
ing L amino acids corresponds to a distribution in the protein sequence space: {P (S =
(s1, s2, ..., sL)) | sj 2 {0, 1, 2, ..., 20}, j = 1, 2, ..., L}, where sj corresponds to the amino
acid type at the jth position of the protein and the amino acid types are labelled using
numbers from 0 to 20 with 0 representing a gap. Such a probabilistic generative model
assigns a proper probability P (S = (s1, s2, ..., sL)) for each protein sequence with L
amino acids. Moreover, new sequences can be sampled from the model based on the pro-
tein family’s sequence distribution. Building a probabilistic generative model of a protein
family’s sequence distribution is useful in several aspects. For example, for a given pro-
tein sequence S = (s1, s2, ..., sL), the probability P (S = (s1, s2, ..., sL)) assigned by the
model measures how likely the sequence belongs to the protein family, which is useful for
searching protein homologies [115]. In addition, new sequences sampled from the model
can be used as candidates for protein engineering. Furthermore, the probability function
P (S = (s1, s2, ..., sL)) of sequences may contain information about dependency between
protein positions, which can be utilized to infer protein residue contact maps and epistasis
effects between protein positions [99, 113, 112, 100, 108, 111, 113].
Two example methods based on probabilistic generative models are sequence profiles
[116, 115] and direct coupling analysis (DCA).[99, 117, 113, 118, 112, 111, 119, 114,
108]. Sequence profiles, widely used for searching homologous sequences, make a strong
assumption that amino acid types at different protein positions are independent, i.e., P (S =
(s1, s2, ..., sL)) =
QL
j=1 Pj(sj) [116, 115]. Ignoring dependency between positions greatly
reduces the number of parameters necessary to model sequence profiles, which makes it
feasible to learn a profile even with a limited number of sequences. In contrast, DCA
approaches model sequence distributions by taking pairwise dependency between protein
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positions into account [99]. Although the number of parameters in DCA is much larger
than that in sequence profiles, multiple studies have shown that, for many protein families,
sequences available in current databases are sufficient to train DCA models that are useful
to predict protein residue contact maps [99, 117, 113, 118, 112, 111, 119, 114] and protein
stability change upon mutation [112, 104] .
Although sequence profiles and DCA have proved to be effective at detecting homol-
ogous sequences and predicting protein residue contact maps, respectively, they are lim-
ited by their inherent assumptions about dependency between protein positions. Sequence
profiles do not model any dependency between protein positions and DCA ignores depen-
dency of more than two positions. However, dependency of more than two positions has
been observed in real proteins and plays important role in shaping evolutionary trajectories
[120, 121, 122]. To overcome these limitations, we propose using variational auto-encoder
models [123] for modeling protein family sequence distributions. As a probabilistic gen-
erative model, compared with sequence profiles and DCA, variational auto-encoder mod-
els do not employ inherent assumptions about dependency between protein positions and
can potentially model dependency among any number of positions. In the work presented
here, with examples of both natural protein families and simulated sequences, it is shown
that variational auto-encoder models are useful for predicting protein stability change upon
mutation, capturing evolutionary relationships between sequences, and delineating protein
fitness landscapes. Our findings suggest that, with an increasing amount of protein se-
quence data, variational auto-encoder models will be useful tools for both the study and
engineering of proteins.
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4.2 Previous Methods
4.2.1 Sequence profiles
Given a protein family’s multiple sequence alignment, sequence profiles [115] model its
sequence distribution by assuming protein positions are independent, i.e.,
P (S = (s1, s2, ..., sL)) =
LY
j=1
Pj(sj), (4.1)
where si 2 {0, 1, 2, ..., 20}; sj represents the amino acid type (labelled using numbers from
0 to 20) at the jth position of the protein; Pj(k) represents the probability that the amino
acid type at the jth position is k. Therefore, a profile model of a protein family with L
amino acids contains 21⇥L parameters which are Pj(k), j = 1, ..., L, k = 0, ..., 20. These
parameters are estimated using the protein family’s multiple sequence alignment:
Pj(k) =
PN
n=1w
n ⇤ I(snj = k)PN
n=1w
n
, (4.2)
whereN is the total number of sequences in the MSA;wn is the weight of the nth sequence;
snj is the amino acid type at the jth position in the nth sequence of the MSA; I(snj = k) is
equal to 1, if snj = k and 0, otherwise. With the estimated parameters, the profile assigns
a probability for any given sequence S with L amino acids based on Eqn. [4.1]. The free
energy of the sequence is calculated as  GProfile(S) =   logP (S).
4.2.2 Direct coupling analysis
The direct coupling analysis (DCA) method [99, 117, 113, 118, 112, 111, 119] models the
probability of each sequence as
P (S = (s1, s2, ..., sL)) =
1
Z
exp( 
"
L 1X
i=1
LX
j=i+1
Jij(si, sj) +
LX
i=1
bi(si)
#
), (4.3)
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where the partition function Z is
Z =
X
s1,s2,...,sL
exp( 
"
L 1X
i=1
LX
j=i+1
Jij(si, sj) +
LX
i=1
bi(si)
#
). (4.4)
The parameters in DCA include the bias term bi(·) for the ith position and the interaction
term Jij(·, ·) between the ith and the jth position of the protein. Learning these parameters
by maximizing likelihood of the model on training data involves calculating the partition
function Z, which is computationally expensive. Therefore, the pseudo-likelihood maxi-
mization method [117] is used to learn these parameters. Similarly as in sequence profiles,
the free energy of a sequence is calculated as
 GDCA(S) =   logP (S) =
L 1X
i=1
LX
j=i+1
Jij(si, sj) +
LX
i=1
bi(si) + logZ. (4.5)
Although the partition function Z is not known, we can still calculate the difference of
 GDCA between two sequences (  GDCA), because the partition function Z is a constant
and does not depend on sequences.
4.2.3 Gaussian process regression
The Gaussian process (GP) regression method [124] is used to fit the fitness (T50) landscape
for chimeric cytochrome P450 sequences. To train a GP regression model, a kernel function
needs to be chosen to specify the covariance between sequences [124]. When the latent
space representation Z is used as the feature vector of sequences, the radial basis function
(RBF) kernel [124] is used:
K(Z1, Z2) =  2 exp( 1
2
||Z1   Z2||2), (4.6)
whereZ1, Z2 are latent space representations of two protein sequences and ||·|| is Euclidean
distance in the latent space. When the binary matrix representationsX , as in Fig. 1, is used
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as the feature vector, the linear kernel is used in GP regression:
K(X1, X2) =  2
21X
i=1
LX
j=1
X1ij ·X2ij, (4.7)
where X1, X2 are two 21⇥ L binary matrices of two protein sequences. The linear kernel
function of two sequences is proportional to the sequence identity of the two sequences.
The parameter  2 in both RBF and linear kernels is estimated by maximizing the likelihood
of the GP model on T50 training data.
4.3 Variational Auto-Encoder
4.3.1 Learning variational auto-encoder (VAE) models of a protein
family’s sequence distribution
In VAE models, a protein sequence S = (s1, s2, ..., sL) is represented as a binary 21 ⇥ L
matrix X for which Xij = 1 if sj = i, and Xij = 0 otherwise (Fig. 4.1). In addition to
the variables X representing sequences, VAE models also include latent space variables Z
that can be viewed as a “code” forX . VAE models define the joint distribution ofX and Z
as p✓(X,Z) = p✓(Z)p✓(X|Z), where ✓ represents parameters of the joint distribution. The
joint distribution p✓(X,Z) = p✓(Z)p✓(X|Z) implies a probabilistic generative process for
(X,Z): the latent variables Z are sampled from a prior distribution p✓(Z) first and then
the sequence variables X are sampled from the conditional distribution p✓(X|Z) given Z.
The conditional distribution p✓(X|Z) acts as a “decoder” that converts “codes” Z into pro-
tein sequences X . Although protein sequences X are discrete random variables, the latent
space variables Z are modeled as continuous random variables. The prior distribution of
Z, p✓(Z), is chosen to be an independent multivariable normal distribution with mean of
zero. The conditional distribution p✓(X|Z) is parameterized using an artificial neuron net-
work with one hidden layer. Given observed sequence data for variables X , learning the
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parameters ✓ that parameterize the generative process is challenging and has been an in-
tensive research topic in machine learning [123]. One reason for the difficulty is that when
the conditional distribution p✓(X|Z) is complex, such as parameterized by a neuron net-
work, the posterior distribution p✓(Z|X) becomes analytically intractable and it is difficult
to even draw samples from it efficiently [123]. In this study, given a protein family’s multi-
ple sequence alignment, the reparameterization trick, first proposed in VAE models [123],
is used to learn the parameters ✓ that include weight and bias parameters in the decoder
neuron network. To remedy the difficulty with the posterior distribution p✓(Z|X), in VAE
models, a reparameterized “encoder” q (Z|X) is introduced to approximate the posterior
distribution p✓(Z|X). In this paper, the encoder q (Z|X) is also parameterized using an
artificial neuron network with one hidden layer (Fig. 4.1).
4.4 Processing sequences in multiple sequence alignments
Before being used as training data for learning VAE models, sequences in multiple se-
quence alignments are processed to remove positions at which too many sequences have
gaps, and sequences with too many gaps. The processing procedure is as the following:
(i) positions at which the query sequence has gaps are removed; (ii) sequences with the
number of gaps larger than 20% of the total length of the query sequence are removed;
(iii) positions at which larger than 20% of sequences have gaps are removed again; (iv)
duplicated sequences are removed.
4.5 Variational auto-encoder
VAE models with the reparameterization trick, introduced for learning Bayesian graphical
models[123], have been successfully applied for several machine learning problems, such
as image and natural language processing [123, 125, 126]. VAE models also have been
applied to discover continuous representations of organic molecules [127]. In this paper, a
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VAE model similar with that in [123] is employed.
4.5.1 Model setup
The prior distribution of Z, p✓(Z), is a m dimensional Gaussian distribution with mean
at the origin and variance being the identity matrix. The decoder model p✓(X|Z) is pa-
rameterized using a fully connected artificial neuron network with one hidden layer as
H = tanh(W1Z + b1) and p✓(X|Z) = softmax(W2H + b2), where the parameters ✓ in-
clude the weights {W1,W2} and the biases {b1, b2}. The encoder model q (Z|X) is chosen
to be a m dimensional Gaussian distribution N (µ,⌃), where ⌃ is a diagonal matrix with
diagonal elements of  2 = ( 21,  22, ...,  2m). The mean µ and the variance  2 are parame-
terized using an artificial neuron network with one hidden layer as H = tanh(W3X + b3),
µ = W4H + b4, log  2 = W5H + b5. The parameters   for the encoder model q (Z|X)
include weights {W3,W4,W5} and biases {b3, b4, b5}.
4.5.2 Model training
The weights of sequences in a protein multiple sequence alignment are calculated using the
position-based sequence weights.[128] Given weighted protein sequences, VAE models
learn the parameters of both encoder and decoder models simultaneously by optimizing the
evidence lower bound objective function (ELBO) [123] which is defined as
ELBO(✓, ) =
X
Z
q (Z|X) log p✓(X|Z) +
X
Z
q (Z|X) log p✓(Z)
q (Z|X) .
To reduce overfitting, a regularization term of   ·P5i=1 k Wi k2F is added to the objective
ELBO(✓, ), where   is called the weight decay factor and k Wi kF is the Frobenius norm
of weight matrix Wi. The gradient of ELBO plus the regularization term with respect
to the model parameters is calculated using the backpropagation algorithm [129] and the
parameters are optimized using the Adam optimizer [130]. The weight decay factor   is
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selected from the set of values {0.0001, 0.0005, 0.001, 0.005, 0.01, 0.05, 0.1} using 5-fold
cross validation (using 10-fold cross validation in the case of cytochrome P450s). In the
cross validation, models trained with different weight decay factors are evaluated based on
the marginal probability assigned by the model on the held-out sequences (based on the
Pearson correlation coefficient in the case of cytochrome P450s).
4.5.3 Calculating the marginal probability of a sequence X , p✓(X)
Given a sequenceX , the marginal probability, p✓(X), is equal to the integral
R
p✓(X,Z)dZ
which is calculated using importance sampling:
p✓(X) =
Z
p✓(X,Z) dZ =
Z
q (Z|X)p✓(X,Z)
q (Z|X) dZ
= E
Z⇠q (Z|X)

p✓(X,Z)
q (Z|X)
 
=
1
N
NX
i=1

p✓(X,Z i)
q (Zi|X)
 
,
where Zi are independent samples from the distribution q (Z|X), and N is number of
samples. In this study, N = 1⇥ 106.
4.6 Simulating multiple sequence alignments
A random phylogenetic tree with 10,000 leaf nodes was generated using the populate func-
tion of the master Tree class from ETE Toolkit [131]. The random branch range is chosen
to be from 0 to 0.3. The LG evolutionary model [132] was used to simulate the sequence
evolution on the generated phylogenetic tree. Sequences from leaf nodes were combined
into a multiple sequence alignment.
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4.7 A predefined protein fitness function
In the predefined protein fitness function, the parameters, Bi(·), represent the contribution
of individual positions and their values are specified by sampling from the normal distribu-
tionN (0, 22). The parameters, Jij(·, ·), corresponds to the epistatic effect between position
i and position j. These are chosen with a probability of 0.95 that there is no epistatic effects
between positions i and j, i.e., Jij(·, ·) = 0. Otherwise, the values of Jij(·, ·) are chosen
from the normal distribution N (0, 1). Similarly, the parameters, Jijk(·, ·, ·), stand for epis-
tasis among positions i, j, and k. These are chosen with a probability of 0.998 that there
is no epistatic effect between positions, i.e., Jijk(·, ·, ·) = 0. Otherwise, their values are
chosen from the normal distribution N (0, 0.52).
4.8 Results and Discussion
4.8.1 Predicting protein stability change upon mutations
With a protein family’s multiple sequence alignment as training data, VAE models learn the
joint distribution of latent space variables Z and sequence variables X: p✓(X,Z). After
learning a VAE model, a marginal probability p✓(X) can be calculated for each sequence
X with L amino acids as p✓(X) =
R
p✓(X,Z)dZ. The marginal probability of a sequence
X , p✓(X), measures how likely it is that the given sequence X belongs to the protein fam-
ily, i.e., how similar the given sequence is to the sequences from the protein family’s MSA.
Because the protein family’s MSA are results of selection in protein evolution, sequences
with higher probability belonging to the protein family’s MSA are expected to have better
adaptation under selection pressures. Selection pressures for protein evolution may include
stability, enzyme activity, drug resistance, or other properties. It can also be a mixture of
different selection pressures. Although different protein families might be under differ-
ent sets of selection pressures in evolution, a common selection pressure shared by many
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structured protein families is protein stability.
To test if a protein sequence’s probability assigned by VAE models correlates with
the sequence’s stability, we applied VAE models for three protein families: fibronectin
type III domain (Pfam accession id: PF00041), staphylococcal nuclease (PF00565), and
phage lysozyme (PF00959). These three protein families were selected because there are
both experimental data on stability change upon mutation [134] and a large number of
sequences in the Pfam database[98] for the three protein families. After processing, the
number of unique sequences in their MSAs is 46498, 7649, and 3560 for fibronectin type
III domain, staphylococcal nuclease, and phage lysozyme, respectively. A VAE model was
trained with these unique sequences for each family and was used to calculate marginal
probabilities of sequences that have experimental folding free energies. To be comparable
with experimental folding free energies, probabilities of sequences, p✓(X), are transformed
into unitless “free energies” by  GVAE(X) =   log p✓(X).
For protein stability change upon single site mutations, the predicted results using VAE
models are compared with experimental results for the three protein families (Fig. 4.2A).
The Pearson’s correlation coefficients between the experimental and predicted results for
fibronectin type III domain, saphylococcal nuclease, and phage lysozyme are 0.81, 0.52,
and 0.43, respectively. The corresponding Spearman’s rank correlation coefficients are
0.85, 0.50, and 0.42, respectively. Protein families with more unique sequences in their
MSAs used as training data tend to have higher correlation coefficients. For example,
fibronectin type III domain, with the largest number of unique sequences in its MSA, has
the highest correlation coefficient among the three protein families. Therefore, the limited
number of unique sequences in their MSAs might be one of the reasons why staphylococcal
nuclease and phage lysozyme have more modest correlation coefficients. The stability
change upon single site mutations is also predicted using sequence profiles and DCA. The
results from both methods are compared with those from the VAE models in terms of
Spearman’s rank correlation coefficients (Fig. 4.2A). The performance of the VAE models
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is comparable with that of sequence profiles and DCA. VAE models are slightly better than
the other two methods for the fibronectin type III domain and staphylococcal nuclease,
which have a relatively larger number of sequences (Fig. 4.2A).
The effects of double and triple site mutations on phage lysozyme’s stability are also
predicted using all three methods. The predicted results are compared with experimental
results [133] in Fig. 4.2B. Because sequence profiles assume that protein positions are
independent and ignore epistasis between positions, its prediction on the effects of multiple
mutations on stability is much poorer than the other two models, both of which take the
dependency between positions into account.
In summary, VAE models are useful for predicting protein stability change as a result
of mutation. For predicting the effect of single site mutations on protein stability, the VAE
model’s performance is comparable with sequence profiles and DCA and becomes better
than the other two methods when a large number of sequences are available. Like DCA,
VAE models also capture the pairwise dependency between positions, which enables DCA
and VAE models to outperform the sequence profile method in predicting the effect of
double and triple site mutations on protein stability. Moreover, VAE models should also be
able to capture dependency among more than two protein positions, which is not modeled
in DCA.
4.8.2 VAE latent space representation captures phylogenetic relation-
ships between sequences
After training with a protein family’s MSA, the VAE encoder, q (Z|X), can be used to em-
bed sequences in a low dimensional continuous latent space, Z. Embedding sequences in
a low dimensional continuous space can be useful for several reasons. The low (2 or 3) di-
mensionality makes it easier to visualize sequence distributions and sequence relationships.
The continuity of the space enables us to apply operations to the family of sequences, such
as interpolation and extrapolation, that are best suited to continuous variables.
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For visualization purposes, the latent space used in this section is 2-dimensional. For
the three protein families: fibronectin type III domain, staphylococcal nuclease, and phage
lysozyme, the latent space embedding of all the sequences from their MSAs is shown in
Fig. S1(A-C). These embedding results show that, in the latent space, sequences are not
distributed randomly. Their distributions have a star structure with multiple spikes, each
of which points from the center towards the outside along a specific direction. The star
structure resembles phylogenetic tree structures that represent phylogenetic relationships
between sequences. To test if the latent space representation can capture phylogenetic re-
lationships between sequences like phylogenetic trees, we applied VAE models on a simu-
lated protein family MSA. The simulated MSA is generated by neutrally evolving a random
protein sequence with 100 amino acids on a simulated phylogenetic tree [131] with 10,000
leaf nodes and combining sequences from all the leaf nodes (Fig. 4.3A). Thus, the phy-
logenetic relationships between sequences in this simulated MSA are known based on the
phylogenetic tree used for simulation.
As with the three protein families shown above, the latent space representation of the
simulated sequences has a similar star structure with multiple separate spikes (Fig. 4.3B),
even though the sequence evolves neutrally in the simulation. As a negative control, a VAE
model is also trained on an MSA consisting of random sequences sampled from the equi-
librium distribution of the LG evolutionary model [132]. The star structure is not observed
in the latent space representation of these random sequences (Fig. S1D), which strongly
supports the idea that the star structure is derived from the evolutionary relationships en-
coded in the tree structure used in the simulation. To compare the latent space star structure
with the phylogenetic tree, sequences are grouped together if they share the same ances-
tor at a reference evolutionary time point based on the phylogenetic tree. Sequences in
the same group have the same color in their latent space representation (Fig. 4.3B). Se-
quences with the same color, i.e., sharing the same ancestor at the chosen time point, are
observed to have their latent space representations in the same spike or multiple adjacent
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spikes (Fig. 4.3B). The multiple adjacent spikes occupied by the same group of sequences
represent more fine-grained phylogenetic relationships between sequences and these more
fine-grained phylogenetic relationships can be recovered by changing the reference time
point used to group the sequences (Fig. 4.3C). Therefore, the spatial organization of the la-
tent space representation of the sequences captures features of the phylogenetic relationship
between sequences.
Another similarity between the star structure in the latent space and the phylogenetic
tree is that the phylogenetic tree originates from the root node and spikes in the star structure
originate from the origin of the latent space (Fig. 4.3B). This similarity is supported by
the observation that the latent space representation of the root node sequence is near the
origin of the latent space (Fig. 4.3D). Furthermore, to see how a sequence’s latent space
representation moves in the latent space as the sequence evolves, both leaf node sequences
and their corresponding ancestral sequences are projected into the latent space. For a leaf
node sequence and its corresponding ancestral sequences, the primary moving direction is
calculated as the first component direction using principal component analysis (Fig. 4.3D).
It is shown that a sequence’s distance from the origin along the moving direction in the
latent space is highly correlated with the sequence’s evolutionary distance from the root
node sequence (Fig. 4.3D and E). This correlation suggests that as sequences evolve from
the root node towards leaf nodes in the phylogenetic tree, their latent space representations
move from the origin of the latent space towards the outside along specific directions (Fig.
4.3D). This pattern holds for most of the leaf node sequences and their corresponding
ancestral sequences (Fig. 4.3F).
The comparison between the phylogenetic tree structure and the latent space repre-
sentation of sequences demonstrates that the VAE latent space representation can capture
similar phylogenetic relationships between sequences as does the phylogenetic tree. Phy-
logenetically close sequences are clustered spatially together as spikes in the latent space.
In addition, as a sequence evolves, its latent space representation moves from the origin
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towards the outside along a spike. These phylogenetic relationships captured in the VAE’s
latent space representation make the VAE a potentially useful tool for studying protein evo-
lution. Compared with traditional phylogenetic trees, VAE models does not require choos-
ing a specific evolutionary model. Moreover, VAE models can work with a much larger
number of sequences (hundreds of thousands of sequences or more) than a phylogenetic
tree, because it does not require the tree structure search or pairwise sequence comparison.
One disadvantage of the VAE model is that it may not be able to capture as many details
of the evolutionary relationships as does the phylogenetic tree. Therefore, a mixture model
of both phylogenetic trees and VAE models might have the best of both approaches for
studying protein evolution.
4.8.3 Navigating the protein fitness landscape in the VAE latent space
A protein’s fitness landscape is a map from the protein’s sequence to the protein’s fitness,
such as the protein’s stability and activity, among a host of other properties. Knowing a pro-
tein’s fitness landscape can greatly assist in studying and engineering proteins with altered
properties. A protein’s fitness landscape can also be viewed as a fitness function in a high
dimensional discrete space of sequences. Because of the high dimensionality and discrete-
ness of this sequence space and the effects of epistasis between different protein positions,
it has been difficult for protein researchers to characterize protein fitness landscapes. As
only a relatively small number of sequences can be synthesized and have experimentally
measured fitness values, a common problem facing researchers is, given the fitness values
for a collection of sequences from a protein family, how does one predict the fitness value
of a new sequence from the same protein family, or design a new sequence which will have
a desired fitness value.
Here we propose a semi-supervised learning framework utilizing the VAE latent space
representation to learn protein fitness landscapes using both protein sequence data and ex-
perimental fitness data (Fig. 4.4D). Although fitness values are usually known for only
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a small subset of sequences from a protein family, we often have access to a large num-
ber of homologous sequences from the same protein family. These sequences represent
functional proteins from species living in different environments. The distribution of these
sequences is shaped by evolutionary selection. Therefore, we expect that the distribution of
these sequences contains information about the relationship between sequence and fitness.
To utilize this information, with a large number of sequences from a protein family, we can
model the distribution of sequences by learning a VAE model for the protein family. The
resulting VAE model provides us with a sequence encoder and a sequence decoder. With
the sequence encoder, sequences are first embedded into a low dimensional continuous
latent space. Then the fitness landscape is estimated in the latent space with experimen-
tal fitness data. With an estimated fitness landscape in the latent space, we can predict
the fitness value of a new sequence using its latent space representation. In addition, we
can also design new sequences with desired fitness values by choosing points in the latent
space based on the fitness landscape and converting these points into sequences using the
VAE decoder (Fig. 4.4D). To test this framework, we applied it to two protein families:
a simulated protein family with a predefined fitness function and the cytochrome P450s
[135, 136, 137].
4.8.4 A simulated protein family with a predefined fitness function
An ideal case to test the above framework would be a protein family whose fitness function
is known. For natural protein families, fitness values are known for only a small number
of sequences. Therefore, we first applied the framework to a simulated protein family for
which a fitness function is predefined as:
Fitness(s1, s2, ..., sL) =
LX
i=1
Bi(si) +
X
1i<jL
Jij(si, sj)
+
X
1i<j<kL
Jijk(si, sj, sk),
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where si is the amino acid type at position i. This fitness function not only includes the
effect of amino acid types at individual positions (Bi(si)), but also includes the effects of
second order (Jij(si, sj)) and third order (Jijk(si, sj, sk)) epistasis. The parameters of the
fitness function, Bi, Jij , and Jijk, are specified using the procedure described inMethods.
The setup used for simulating sequences is the same as in Fig. 4.3 except that as the
sequence evolves along the path from the root node to a randomly chosen leaf node A,
its fitness value has to increase monotonically based on the predefined fitness function
(Fig. 4.4A). Mutations that decrease the fitness value are rejected. The simulated MSA is
used to train a VAE model with a two dimensional latent space and the sequences corre-
sponding to nodes on the path under selection are projected into the latent space using the
VAE encoder (Fig. 4.4B). Similar to the pattern observed in Fig. 4.3D, these sequences
align along a preferred direction in the latent space (Fig. 4.4B) because of their ancestral
relationship. As the sequence evolves from the root node to the leaf node A, its latent space
representation moves away from the origin along a direction which is obtained using the
lowest frequency eigenvector from a principal component analysis of the latent space rep-
resentation of these sequences. Because the fitness value increases monotonically as the
sequence evolves along the path, the sequences’ fitness values correlate with their posi-
tions in latent space along the principal component eigenvector direction (orange points in
Fig. 4.4C). This correlation can be viewed as the fitness landscape along the eigenvector
direction, but it is observed only at a finite number of discrete points. Does this correla-
tion hold continuously along this direction? To answer this question, 300 points, uniformly
distributed along the eigenvector direction, were converted into protein sequences using
the VAE decoder and their fitness values are calculated with the predefined fitness func-
tion (blue points in Fig. 4.4C). For these decoded sequences, fitness values also correlate
with their positions along the eigenvector direction in the latent space (Fig. 4.4C). Be-
cause the correlation holds continuously, it is useful to not only predict fitness of sequences
whose latent space representation lies along this eigenvector, but also to design sequences
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that have fitness values in between by interpolating sequences through their latent space
representation.
4.8.5 Cytochrome P450
The cytochrome P450 protein family was chosen to test our framework because there are
both experimental fitness data and a large number of sequences available for the protein
family. The Arnold group made a library of 6561 chimeric cytochrome P450 sequences
by recombining three cytochrome P450s (CYP102A1, CYP102A2, CYP102A3) at seven
crossover locations [135] (Fig. S2) and measured T50 values (the temperature at which 50%
of the protein is inactivated irreversibly after 10 minutes) for 278 sequences [135, 136, 137].
In addition to these experimental T50 fitness data, the cytochrome P450 family (PF00067)
has more than 28K unique homologous sequences in its MSA from the Pfam database [98].
For visualization purposes, we first trained a VAE model with a two dimensional latent
space. Embedding the 28K sequences from its MSA (Fig. S3A) shows that the latent space
representation of these sequences has a similar star structure as observed in Fig. 4.3B.
Comparing the latent space representation of sequences from the MSA (Fig. S3A) with
that of chimeric sequences (Fig. S3B), we can see that the 6561 chimeric sequences, made
by all possible recombinations of three proteins at seven crossover locations, only occupy a
small fraction of latent space available for the protein family. This suggests that most of the
sequence space of cytochrome P450 is not covered by these chimeric sequences. Therefore,
the two dimensional latent space representation, though simple, is useful to estimate how
much sequence space has been covered by a set of sequences. In addition, it can also
potentially guide designing sequences from the unexplored sequence space by converting
points in the unexplored latent space region into sequences using the VAE decoder.
Embedding the sequences which have T50 data into the two dimensional latent space
and coloring the sequences based on their fitness values provide a way to visualize the
fitness landscape (Fig. S3C). As the fitness landscape is not necessarily linear, Gaussian
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processes are used to fit a continuous fitness surface using the two dimensional latent space
representation as features and using the radial basis function (RBF) kernel with Euclidean
distance. The 278 sequences with T50 experimental data are randomly separated into a
training set of 222 sequences and a testing set of 56 sequences. Based on 10-fold cross
validation on the training set, just using the two dimensional latent space representation
of sequences which have 466 amino acids, the Gaussian process model can predict the
T50 values for the training set with a Pearson correlation coefficient of 0.80 ± 0.06 and a
MAD (mean absolute deviation) of 3.2± 0.4 C (Fig. S3D). For the testing set, the Pearson
correlation coefficient is 0.84 and the MAD is 2.9 C.
As the method is not restricted to two dimensional latent spaces, VAE models with
latent spaces of different dimensionality combined with Gaussian processes may also used
to predict the T50 experimental data. Based on 10-fold cross validation Pearson correlation
coefficients, the VAE model with a 30 dimensional latent space works the best with a
Pearson correlation coefficient of 0.93 ± 0.02 and a MAD of 1.9 ± 0.2 C on the training
set (Fig. 4.4E). On the testing set, the Pearson correlation coefficient is 0.93 and the MAD
is 2.0 C.
We note that Gaussian processes have been used before to learn the T50 fitness land-
scape of cytochrome P450 either employing sequences as features with a structure based
kernel function [136] or using embedding representations [138]. Compared with previous
methods [136, 138], one difference of our method lies in the embedding method. The em-
bedding method used in this study is the VAE encoder learned by modeling the sequence
distribution of the protein family. Therefore, it utilizes information specific to the protein
family. In contrast, the embedding method proposed in [138] is a generic doc2vec embed-
ding method, which is learned by pooling sequences from many protein families together
and viewing all protein sequences equally. Another difference with our method is that
points in the embedding space, i.e., the latent space, can be converted into sequences using
the VAE decoder. Therefore, the transformation between sequence space and embedding
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space is a two-way transformation, instead of one way as in [138]. This enables our ap-
proach to be used to propose new sequences based on the fitness landscape in the latent
space.
4.9 Conclusion
Using both simulated and experimental data, we have demonstrated that VAE models,
trained only with MSAs of protein families, can predict protein stability change upon mu-
tation and learn phylogenetic relationships between sequences. Unlike the sequence profile
method and the DCA method, VAE models can potentially model amino acid dependency
among any number of protein positions. Compared with phylogenetic trees, to learn phy-
logenetic relationships between sequences, VAE models do not assume a predefined evolu-
tionary model and can work with a much larger number of sequences. When experimental
data on protein fitness is available for a subset of sequences, VAE models can also help
learn fitness landscapes with the low dimensional continuous latent space representation
of sequences. With an estimated fitness landscape in the latent space and the two-way
transformation between the latent space and the sequence space, the VAE models can not
only predict fitness values of sequences, but also help design new candidate sequences with
desired fitness for experimental synthesis and validation. With the advance of sequencing
technology, the amount of protein sequence data that are available to train VAE models
increases rapidly. Moreover, recent deep mutational scanning experiments are generating
large-scale data sets of the relationship between protein sequences and function [139]. With
this increasing amount of both protein sequence and fitness data, the VAE model will be
a useful tool to learn information about protein stability, evolution, and fitness landscapes
and provide insights into the engineering of proteins with modified properties.
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Figure 4.1: Encoder and decoder models used in the variational auto-encoder. Both
encoder and decoder models used in this paper are fully connected artificial neuron net-
works with one hidden layer H . The encoder model transforms each protein sequence X
into a distribution q (Z|X) of Z in the latent space; the decoder model transforms each
point in the latent space Z into a distribution p✓(X|Z) of X in the protein sequence space.
In both models, protein sequences from a multiple sequence alignment with L amino acids
are represented as a 21⇥Lmatrix whose entries are either 0 or 1 based on a one-hot coding
scheme. Gaps in sequences are modeled as an extra amino acid type.
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Figure 4.2: Predicting protein stability change upon mutations. (A) (Top) Correlation
between experimental results and predicted results using VAE models on protein stability
change upon single mutations for fibronectin type III domain (left), staphylococcal nu-
clease (middle), and phage lysozyme (right).   Gexp is experimental protein folding free
energy change upon single mutations compared with the wild type protein.   GVAE is pre-
dicted protein stability change upon single mutations using VAE.  GVAE is calculated as
the change of negative log-likelihood of sequences when single mutations are introduced.
Therefore,   GVAE is an unitless quantity. Each point corresponds to a mutant sequence
with one mutation compared with the wild type sequence. r and ⇢ are Pearson’s correla-
tion coefficients and Spearman’s rank correlation coefficients, respectively. (Bottom) In
addition to VAE models, protein stability change upon single mutations are also predicted
using sequence profiles and DCA. Spearman’s rank correlation coefficients between exper-
imental results and predicted results using the three methods are compared for the same
three protein families. (B) Correlation between experimental results and predicted results
on protein stability change upon single ( ), double (+) and triple (4) mutations for phage
lysozyme using profiles (left), DCA (middle), and VAE (right) models. The estimated
measurement error in  Gexp is±0.2 kcal/mol [133]. We note that the correlations shown
here are results on testing sets because the experimental folding free energy changes are
not used in training the VAE model.
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Figure 4.3: VAE latent space representation of sequences captures phylogenetic rela-
tionships between sequences. (A) A schematic representation of the phylogenetic tree
used for simulating evolution of a random protein sequence with 100 amino acids. The
actual tree used has 10,000 leaf nodes. Dash lines, ↵ and  , represent two reference evolu-
tionary time points on which sequences of leaf nodes are grouped. Sequences of leaf nodes
are in the same group if they share the same ancestor at the reference time point, either ↵
or  . (B) VAE latent space representation of sequences of all leaf nodes. The sequence of
each leaf node is projected into the 2-dimensional latent space onto the point Eq (Z|X)Z,
where Z = (Z1, Z2) based on the VAE encoder q (Z|X). Sequences are separated into
groups at the reference time point ↵, which has an evolutionary distance of 0.5 from the
root node. Sequences in the same group have the same color. (C) Sequences from the yel-
low colored group in (B) are regrouped and recolored based on the reference time point  ,
which has an evolutionary distance of 0.92 from the node. (D) VAE latent space represen-
tation of four representative leaf node sequences, labelled as plus signs, and their ancestral
sequences, labelled as dots. Sequences are colored based on their evolutionary distances
from the root node. The sequence of the root node sits around the origin in the latent space.
As the sequence evolves from the root node to a leaf node, its latent space representation
moves from the origin towards the surroundings along a direction. The moving direction,
labelled as a dashed arrow line for the right most leaf node, is calculated as the first com-
ponent direction using the principal component analysis. (E) For the leaf node sequence at
the rightmost of (D) and its corresponding ancestry sequences, their coordinates along the
moving direction correlates with their evolutionary distances from the root node. (F) The
distribution of Pearson’s correlation coefficients of all leaf node sequences, as calculated in
(E).
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Figure 4.4: Navigating the protein fitness landscape in the VAE latent space. (A) A
schematic representation of the phylogenetic tree used for simulating evolution of a ran-
dom protein sequence with 100 amino acids. The simulation setup is the same as that
in Fig. 4.3A except that a selection pressure with a predefined fitness function is applied
through the path (bold) from the root node to a leaf node A. Therefore, fitness of sequences
increases monotonically along the path. (B) Latent space representation of sequences cor-
responding to the nodes along the bold path in (A). Color represents fitness values of se-
quences. Red plus sign represents the position of the leaf node sequence. Dashed arrow
line represents the primary moving direction, which is used in (C). (C) (Orange) Fitness of
sequences from both the leaf node and the ancestral nodes along the path under selection.
(Blue) Fitness of interpolated sequences which are calculated by decoding points along the
primary moving direction in the latent space into sequences. (D) The proposed framework
on how VAE latent space representation of sequences can be combined with other methods,
such as Gaussian processes in this study, to predict fitness of a new sequence and to design
a new sequence with specified fitness values. (E) Correlation between predicted T50 and
experimental T50 for P450 chimera sequences in testing set.
71
(A) (B)
(C) (D)
Figure 4.5: Two dimensional latent space representations of sequences from multiple se-
quence alignments for protein families: fibronectin type III domain (A), staphylococcal
nuclease (B), and phage lysozyme (C). A two dimensional latent space representation of
random sequences with 100 amino acids sampled from the equilibrium distributions of the
LG evolutionary model (D).
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CYP102A1    .TIKEMPQPKTFGELKNLPLLNTDKPVQALMKIADELGEIFKFEAPGRVTRYLSSQRLIKEACDESRFDK
CYP102A2    KETSPIPQPKTFGPLGNLPLIDKDKPTLSLIKLAEEQGPIFQIHTPAGTTIVVSGHELVKEVCDEERFDK
CYP102A3    KQASAIPQPKTYGPLKNLPHLEKEQLSQSLWRIADELGPIFRFDFPGVSSVFVSGHNLVAEVCDEKRFDK
CYP102A1    NLSQALKFVRDFAGDGLATSWTHEKNWKKAHNILLPSFSQQAMKGYHAMMVDIAVQLVQKWERLNADEHI
CYP102A2    SIEGALEKVRAFSGDGLATSWTHEPNWRKAHNILMPTFSQRAMKDYHEKMVDIAVQLIQKWARLNPNEAV
CYP102A3    NLGKGLQKVREFGGDGLATSWTHEPNWQKAHRILLPSFSQKAMKGYHSMMLDIATQLIQKWSRLNPNEEI
CYP102A1    EVPEDMTRLTLDTIGLCGFNYRFNSFYRDQPHPFITSMVRALDEAMNKLQRANPDDPAYDENKRQFQEDI
CYP102A2    DVPGDMTRLTLDTIGLCGFNYRFNSYYRETPHPFINSMVRALDEAMHQMQRLDVQDKLMVRTKRQFRYDI
CYP102A3    DVADDMTRLTLDTIGLCGFNYRFNSFYRDSQHPFITSMLRALKEAMNQSKRLGLQDKMMVKTKLQFQKDI
CYP102A1    KVMNDLVDKIIADRKASGEQ.SDDLLTHMLNGKDPETGEPLDDENIRYQIITFLIAGHETTSGLLSFALY
CYP102A2    QTMFSLVDSIIAERRANGDQDEKDLLARMLNVEDPETGEKLDDENIRFQIITFLIAGHETTSGLLSFATY
CYP102A3    EVMNSLVDRMIAERKANPDENIKDLLSLMLYAKDPVTGETLDDENIRYQIITFLIAGHETTSGLLSFAIY
CYP102A1    FLVKNPHVLQKAAEEAARVLVDPVPSYKQVKQLKYVGMVLNEALRLWPTAPAFSLYAKEDTVLGGEYPLE
CYP102A2    FLLKHPDKLKKAYEEVDRVLTDAAPTYKQVLELTYIRMILNESLRLWPTAPAFSLYPKEDTVIGGKFPIT
CYP102A3    CLLTHPEKLKKAQEEADRVLTDDTPEYKQIQQLKYIRMVLNETLRLYPTAPAFSLYAKEDTVLGGEYPIS
CYP102A1    KGDELMVLIPQLHRDKTIWGDDVEEFRPERFENPSAIPQHAFKPFGNGQRACIGQQFALHEATLVLGMML
CYP102A2    TNDRISVLIPQLHRDRDAWGKDAEEFRPERFEHQDQVPHHAYKPFGNGQRACIGMQFALHEATLVLGMIL
CYP102A3    KGQPVTVLIPKLHRDQNAWGPDAEDFRPERFEDPSSIPHHAYKPFGNGQRACIGMQFALQEATMVLGLVL
CYP102A1    KHFDFEDHTNYELDIKETLTLKPEGFVVKAKSKKIPLGGIPSPST.
CYP102A2    KYFTLIDHENYELDIKQTLTLKPGDFHISVQSRHQEAIHADVQAAE
CYP102A3    KHFELINHTGYELKIKEALTIKPDDFKITVKPRKTAAINVQRKEQA
Figure 4.6: Sequences of the three parent cytochrome P450s (CYP102A1, CYP102A2,
CYP102A3). The chimeric sequences are made by recombining the three proteins at the
seven cross over locations marked by arrows [135].
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Figure 4.7: Latent space representations of sequences for cytochrome P450 family and its
fitness landscape. (A) A two dimensional latent space representation of sequences for cy-
tochrome P450 family (PF00067). (B) The two dimensional latent space representation
of 6561 chimeric cytochrome P450 sequences made by combining the three cytochromes
P450 (CYP102A1, CYP102A2, CYP102A3) at seven crossover locations. (C) The two di-
mensional latent space representation of 278 chimeric cytochrome P450 sequences whose
T50 values are measured experimentally by the Arnold group. Each point represents a
chimeric cytochrome P450 sequence. Points are colored by their experimental T50 val-
ues. (D) The Gaussian process’s performance at predicting T50 on the training set of 222
chimeric cytochrome P450 sequences using the two dimensional latent space representation
(Z1, Z2) as features and using the radial basis function kernel with Euclidean distance in
latent space Z. (E) The performance of the Gaussian process model from (D) at predicting
T50 on the testing set of 56 chimeric cytochrome P450 sequences. (F) The Gaussian pro-
cess’s performance at predicting T50 on the training set of 222 chimeric cytochrome P450
sequences using the 30 dimensional latent space representation (Z1, ..., Z30) as features and
using the radial basis function kernel with Euclidean distance in latent space Z.
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CHAPTER 5
Discussion and Conclusions
In the previous chapters three methodological advances have been developed and presented
for both drug discovery and protein engineering. Although these advances do solve several
problems in drug discovery and protein engineering, they are still far from perfect and can
be further improved. Moreover, in addition to the applications shown in the dissertation,
these advances also have potential to be used in other applications. Therefore, the first pur-
pose of this chapter is to share with the reader how these advances can be further improved
and used in other applications.
The significant speedup achieved by the FFT docking on GPUs for searching ligands’
translational and rotational space can be used to rank ligand docking conformations in
protein-ligand docking. In most current protein-ligand docking programs, ligand confor-
mations are ranked by their interaction energies with proteins, which does not take the
entropic effects into account explicitly[13, 14, 12, 7, 9]. With the FFT docking, a Boltz-
mann weighted energy can be calculated by calculating interaction energies of a ligand
conformation with proteins for all of its positions and orientations and taking a Boltzmann
average of these energies. This explicit way of incorporating the entropic effects of lig-
and translations and rotations into ranking ligand docking conformations has the potential
to improve the ranking accuracy of the initial scoring function. The current implementa-
tion of parallel MD simulated annealing running on a GPU is only 20 times faster than
the original simulated annealing running on a CPU when 500 trials of simulated anneal-
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ing are used. One of the reasons that the speedup is only 20 is that the implementation
is using OpenMM[36] and a large fraction of computing time is spent on constructing the
OpenMM context. Therefore, implementing the parallel MD simulated annealing directly
using CUDA might be able to accelerate the calculation much further beyond a speedup of
20 times.
The Gibbs sampler  -dynamics (GSLD) approach for free energy calculation is only
applied to small test systems in the dissertation[8]. Like  -dynamics, GSLD can also be
extended to calculate free energies for a large number of states simultaneously. One particu-
lar suitable application of this extension will be the use of GSLD for constant pH molecular
dynamics, which can provide information on how pH affects the dynamics of a biological
system. In the dissertation, the Rao-Blackwell estimator is shown to not only address the
biasing problem of the empirical estimator but also provide a new understanding of the
multistate Bennett acceptance ratio (MBAR) equations[66]. This new way of understand-
ing the MBAR equations has inspired us to develop a fast solver for solving large scale
MBAR equations and a manuscript describing this new fast solver is in preparation.
The variational auto-encoder (VAE) approach [123] for learning protein stability, evo-
lution, and fitness landscape information from protein sequences is still in an early stage
and several questions are worth further investigation. For instance, considering that the
VAE approach can work with a large number of sequences, an effective way to combine
it with tools from evolutionary biology to help build phylogenetic trees of a large number
of sequences can provide a very useful tool for evolutionary biologists. One limitation of
the proposed VAE approach is that its input needs to be protein sequences from a multiple
sequence alignment (MSA) and obtaining MSAs is much more difficult than collecting pro-
tein sequences. Therefore, a very useful extension of the current VAE approach is to make
it work with unaligned protein sequences, which can significantly increase the amount of
data available to train the model. Moreover, working with unaligned protein sequences
could also enable the VAE method to model the sequence distribution of multiple protein
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families, which might be able to provide insights into the evolutionary relationship between
protein families in addition to the evolutionary relationship between sequences in the same
protein family. Another straightforward application of the VAE approach is for analyz-
ing RNA sequences, because, similar to protein sequences, RNA sequences can also be
clustered into different families and combined into sequence alignments [140].
These methodological advances are made by combining and adapting theories, meth-
ods, and tools from multiple disciplines including statistical mechanics, statistics, machine
learning, and computer science. In studying theories and methods from different disci-
plines and developing new interdisciplinary methods, I have learned several lessons about
how different research fields are closely connected and how new methods developed in one
field can have a big impact in another field. Therefore, it is the second purpose of this
chapter to share some of these lessons.
Free energy has been a quantity of great interest to calculate in statistical mechanics
and computational chemistry. At the same time, free energy is also a quantity of interest in
statistics, especially in Bayesian statistics. In Bayesian statistics, calculating free energies
is usually known as calculating normalization constants or calculating evidence, which
is necessary when deciding which model/assumption is more convincing given observed
data. Therefore, researchers from both statistical mechanics and Bayesian statistics have
been developing similar or equivalent methods for calculating free energies. For example,
the free energy perturbation (FEP) method using the Zwanzig equation developed in sta-
tistical mechanics is equivalent to the importance sampling method developed in statistics,
although they were developed independently in the two fields in 1950s [51, 141]. In 1976,
the Bennett acceptance ratio (BAR) method was developed in statistical mechanics and it
is a much better method than the FEP method for calculating free energies [142]. However,
the BAR method was not widely known or used in statistics until 20 years later in 1998
when the BAR method was introduced and analyzed in statistics[143]. This shows that,
despite the fact that researchers from both fields are trying to solving the same problem,
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sometimes researchers from one field are not aware of progress made in the other field
and it takes a long time for a new idea proposed in one field to be borrowed and have an
impact on another field. In addition to the free energy methods mentioned above, another
research area shared by both statistical mechanics and Bayesian statistics is development
of enhanced sampling methods. Making connections between enhanced sampling methods
that have been developed in the two disciplines could provide insights and help develop
better sampling methods that can benefit both fields.
The last lesson I want to share is that, during the last 10 years or so, there have been
great advances in machine learning, especially in the area of unsupervised learning[123,
144, 145]. Combined with the availability of a large amount of data, these advances have
been making large impacts on traditional machine learning areas such as image processing,
recommendation systems, and natural language processing[145]. Due to the advances of
both imaging and sequencing technology in biology, the amount of data in biology and
medicine, especially sequence data, has been rapidly increasing [98, 97, 140]. Most of
these data in biology is unlabelled. Therefore, unsupervised learning methods are required
to learn valuable information from the large amount of unlabelled data. The application of
the new advances in unsupervised machine learning methods in biology and medicine is
still in a starting stage and should be a research area worth much further investigation.
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